Document:

Exhibit 10.2

 

SUBSCRIPTION AGREEMENT

 

This SUBSCRIPTION AGREEMENT (this “Subscription
Agreement”) is entered into on November 30, 2021, by and between Broadscale Acquisition Corp., a Delaware corporation
(the “Issuer”), and the subscriber
party set forth on the signature page hereto (“Subscriber”).

 

WHEREAS, substantially concurrently with the execution
of this Subscription Agreement, the Issuer is entering into an Agreement and Plan of Merger, by and among the Issuer, Velocity Merger
Sub Inc., a Delaware corporation (“MergerSub”),
and Voltus, Inc., a Delaware corporation (“Target”)
(the “Merger Agreement”), whereby
MergerSub will merge with and into Target, with Target surviving as a wholly owned subsidiary of the Issuer, on the terms and subject
to the conditions set forth therein (the “Transactions”);

 

WHEREAS, to finance a portion of the Transactions,
Subscriber desires to subscribe for and purchase from the Issuer [(i)] that number of shares of the Issuer’s Class A common
stock, par value $0.0001 per share (the “Class A
Shares”), set forth on the signature page hereto (the “Acquired
Shares”) [and (ii) that number of warrants (the “Warrants”) set forth on the signature page hereto
exercisable for Class A Shares pursuant to the terms and subject to the conditions set forth in the form of warrant agreement attached
hereto as Exhibit A (the “Closing Warrants” and the Closing Warrants together with the Acquired Shares, the “Securities”)]1
in a private placement for an aggregate purchase price for the subscribed Securities set forth on the signature page hereto (the “Purchase
Price”), and the Issuer desires to issue and sell to Subscriber the Securities in consideration of the payment of the
Purchase Price by or on behalf of Subscriber to the Issuer on or prior to the Subscription Closing (as defined below);

 

WHEREAS, to finance a portion of the Transactions,
substantially concurrently with the execution of this Subscription Agreement, Issuer is entering into (a) separate subscription agreements
with affiliates of Nokomis ESG Sponsor, LLC (collectively, the “Insider PIPE Investors,” and such investment the “Insider
PIPE Investment”), (b) [a separate subscription agreement with a certain strategic investor who is also entering into certain
other commercial or strategic arrangements with the Issuer (the “Strategic Investor” and such investment the “Strategic
Investor Investment”) and (c)]2
separate subscription agreements with certain other “qualified institutional buyers” (as such term is defined under Rule 144A
of the Securities Act of 1933, as amended (the “Securities
Act”)), and “accredited investors” (as such term is defined in Rule 501 under the Securities Act) (other
than the Insider PIPE Investors [and the Strategic Investor], the “Other Investors,” and such other subscription agreements,
the “Other Subscription Agreements”)
with an aggregate purchase price of $100,000,000 (inclusive of the Purchase Price[, the Strategic Investor Investment] and the Insider
PIPE Investment).

 

NOW, THEREFORE, in consideration of the foregoing
and the mutual representations, warranties and covenants, and subject to the conditions, herein contained, and intending to be legally
bound hereby, the parties hereto hereby agree as follows:

 

1. Subscription.
Subject to the terms and conditions hereof, Subscriber hereby irrevocably agrees to subscribe for and purchase, and the Issuer hereby
agrees to issue and sell to Subscriber, upon the payment of the Purchase Price, the Securities (such subscription and issuance, the “Subscription”). 

 

 

		1	Closing Warrants will only be issued to investors who have subscribed
for more than a certain number of shares and certain other investors. For investors who will not be issued the Closing Warrants, references
herein to “Securities” are replaced with references to “Acquired Shares.”

		2	References to Strategic Investor only included for certain investors
who subscribed for more than a certain number of shares.

  

    

     

    

 

2. Subscription
Closing.

 

(a) The closing of the Subscription
contemplated hereby (the “Subscription Closing”)
shall occur substantially concurrent with, and be conditioned upon the prior or substantially concurrent consummation of the Transactions
(the “Closing Date”). Not less
than five (5) business days prior to the anticipated Closing Date, the Issuer shall provide written notice to Subscriber (the “Closing
Notice”) of such anticipated Closing Date. Subscriber shall deliver to the Issuer on or before three (3) business days
prior to the anticipated Closing Date (the “Funding
Date”) the Purchase Price for the Securities by wire transfer of U.S. dollars in immediately available funds to the
account specified by the Issuer in the Closing Notice, to be held by the Issuer until the Closing Date. On the Closing Date the Issuer
shall deliver to Subscriber the Securities in book entry form, free and clear of any liens or other restrictions (other than those arising
under this Subscription Agreement or applicable securities laws or imposed by the Subscriber) in the name of Subscriber (or its nominee
in accordance with its delivery instructions) or to a custodian designated by Subscriber, as applicable, and no later than one (1) Business
Day after the Closing Date, the Issuer shall deliver to Subscriber a copy of the records of the Issuer’s transfer agent (the “Transfer
Agent”) or other evidence showing Subscriber as the owner of the Securities on and as of the Closing Date. For purposes
of this Subscription Agreement, “business day”
shall mean a day, other than a Saturday, Sunday or other day on which commercial banks in New York, New York are authorized or required
by law to close. Prior to or at the Closing, Subscriber shall deliver to Issuer a duly completed and executed Internal Revenue Service
Form W-9 or appropriate Form W-8. In the event the Closing Date does not occur within two (2) business days after the Subscription Closing,
the Issuer shall promptly (but not later than one (1) business day thereafter) return the Purchase Price to Subscriber by wire transfer
of U.S. dollars in immediately available funds to the account specified by Subscriber, and any book entries or share certificates shall
be deemed repurchased and cancelled; provided that unless this Subscription Agreement has been terminated pursuant to Section
6 hereof, such return of funds shall not terminate this Subscription Agreement or relieve Subscriber of its obligation to purchase
the Securities at the Subscription Closing.

 

(b) The
Subscription Closing shall be subject to the conditions that, on the Closing Date:

 

(i) (x)
solely with respect to the Subscriber’s obligation to close, the representations and warranties made by the Issuer in Section
3 of this Subscription Agreement shall be true and correct as of the Closing Date (other than those representations and warranties
expressly made as of an earlier date, which shall be true and correct as of such date) except for inaccuracies or the failure of such
representations and warranties to be true and correct that (without giving effect to any limitation as to “materiality” or
“Issuer Material Adverse Effect” (as defined below) or another similar materiality qualification set forth herein), individually
or in the aggregate, would not reasonably be expected to have an Issuer Material Adverse Effect; and (y) solely with respect to the Issuer’s
obligation to close, the representations and warranties made by the Subscriber in Section 4 of this Subscription Agreement shall
be true and correct as of the Closing Date (other than those representations and warranties expressly made as of an earlier date, which
shall be true and correct as of such date) except for inaccuracies or the failure of such representations and warranties to be true and
correct that (without giving effect to any limitation as to “materiality” or “Subscriber Material Adverse Effect”
(as defined below) or another similar materiality qualification set forth herein), individually or in the aggregate, would not reasonably
be expected to have a Subscriber Material Adverse Effect, and in each case of (x) and (y) without giving effect to the consummation of
the Transactions;

 

(ii) all
conditions precedent to the closing of the Transactions set forth in the Merger Agreement shall have been satisfied or waived in accordance
with the Merger Agreement other than those conditions that by their terms are to be satisfied at the Closing Date (but subject to the
satisfaction or waiver thereof);

 

(iii) the
Merger Agreement (other than the condition in Section 9.3(c) of the Merger Agreement or the effects thereof) shall not have been amended,
modified or waived by the Issuer in a manner that would reasonably be expected to materially adversely affect the economic benefits that
Subscriber would reasonably expect to receive under this Subscription Agreement (it being understood that any such amendment, modification
or waiver resulting in a decrease in the valuation of the Target in connection with the Transactions and/or the failure by one or more
Other Investors to meet their closing funding obligations in violation of the Subscription Agreements would not have such a material and
adverse effect); and

 

    2

     

    

 

(iv) there
shall not be any law or order of any governmental authority having jurisdiction restraining, enjoining or otherwise prohibiting or making
illegal the consummation of the transactions contemplated by this Subscription Agreement.

 

(c) At
the Subscription Closing, the parties hereto shall execute and deliver such additional documents and take such additional actions as the
parties reasonably may deem necessary in order to consummate the Subscription as contemplated by this Subscription Agreement.

 

3. Issuer
Representations and Warranties. The Issuer represents and warrants that (provided that no representation or warranty by Issuer shall
apply to any statement or information in the reports filed by Issuer with the Commission (as defined below) since November 5, 2020 that
relates to the topics referenced in the SEC Statement (as defined below), nor shall any correction, amendment or restatement of Issuer’s
financial statements due wholly or in part to the SEC Statement or any other accounting matters, nor any other effects that relate to
or arise out of, or are in connection with or in response to, any of the foregoing or any changes in accounting or disclosure related
thereto, be deemed to be a breach of any representation or warranty by Issuer):

 

(a) The
Issuer has been duly incorporated and is validly existing as a corporation in good standing under the laws of the State of Delaware, with
corporate power and authority to own, lease and operate its properties and conduct its business as presently conducted and, subject to
obtaining all approvals necessary for the consummation of the Transactions (collectively, the “Required
Approvals”), to enter into, deliver and perform its obligations under this Subscription Agreement.

 

(b) As
of the Subscription Closing, the Securities will have been duly authorized by the Issuer. The Acquired Shares, when issued and delivered
to Subscriber against full payment of the Purchase Price in accordance with the terms of this Subscription Agreement and registered with
the Transfer Agent, the Acquired Shares will be validly issued, fully paid and non-assessable[. The Warrants, when issued and delivered
to Subscriber against full payment of the Purchase Price in accordance with the terms of this Subscription Agreement and the Warrant Agreement,
will constitute the valid and binding obligations of the Issuer, enforceable against the Issuer in accordance with their terms, except
as may be limited or otherwise affected by (i) the effect of bankruptcy, insolvency, reorganization, fraudulent transfer, moratorium
or other similar laws relating to or affecting the rights and remedies of creditors; (ii) the effect of general principles of equity,
whether considered in a proceeding in equity or at law (including the possible unavailability of specific performance or injunctive relief),
concepts of materiality, reasonableness, good faith and fair dealing, and the discretion of the court before which a proceeding is brought.
The Securities,]3 [and] when so issued and
delivered, will not have been issued in violation of or subject to any preemptive or similar rights created under the Issuer’s certificate
of incorporation and bylaws or under the laws of the State of Delaware. [As of the Subscription Closing, the Issuer shall have reserved
an amount of duly authorized Class A Shares that is equal to the number of Class A Shares issuable upon the exercise of the Closing Warrants.
The Class A Shares issued to Subscriber upon the exercise of any Closing Warrant will be validly issued, fully paid and non-assessable.]4

 

(c) This
Subscription Agreement has been duly authorized, executed and delivered by the Issuer and assuming the due authorization, execution and
delivery of the same by the Subscriber, is enforceable against it in accordance with its terms, except as may be limited or otherwise
affected by (i) bankruptcy, insolvency, reorganization, fraudulent conveyance, arrangement, moratorium or other laws relating to
or affecting the rights of creditors generally, and (ii) principles of equity, whether considered at law or equity.

 

 

		3	Only included for investors who are being issued Closing Warrants.

		4	Only included for investors who are being issued Closing Warrants.

 

    3

     

    

 

(d) Subject
to obtaining the Required Approvals and assuming the accuracy of the Subscribers’ representations and warranties in Section 4,
the execution, delivery and performance by the Issuer of this Subscription Agreement, including the issuance and sale of the Securities,
will not conflict with or result in a breach or violation of any of the terms or provisions of, or constitute a default under, or result
in the creation or imposition of any lien, charge or encumbrance upon any of the property or assets of the Issuer pursuant to the terms
of (i) any indenture, mortgage, deed of trust, loan agreement, lease, license or other agreement or instrument to which the Issuer
is a party or by which the Issuer is bound or to which any of the property or assets of the Issuer is subject; (ii) the organizational
documents of the Issuer; or (iii) any statute or any judgment, order, rule or regulation of any court or governmental agency or body,
domestic or foreign, having jurisdiction over the Issuer or any of its properties that, in the case of clauses (i) and (iii), would be
reasonably likely to have a material adverse effect on the business, financial condition or results of operations of the Issuer and its
subsidiaries taken as a whole or materially and adversely affect the validity of the Securities or the legal authority of the Issuer to
perform in all material respects its obligations hereunder (an “Issuer Material
Adverse Effect”).

 

(e) The
Issuer is not required to obtain any consent, waiver, authorization or order of, give any notice to, or make any filing or registration
with, any court or other federal, state, local or other governmental authority, self-regulatory organization or other person in connection
with the execution, delivery and performance by the Issuer of this Subscription Agreement (including, without limitation, the issuance
of the Securities), other than (i) filings with the Securities and Exchange Commission (the “Commission”),
(ii) in connection with or as a result of the “Staff Statement on Accounting and Reporting Considerations for Warrants Issued by
Special Purpose Acquisition Companies” issued by the Commission staff on April 12, 2021 or any subsequent guidance, statements or
interpretations issued by the Commission or the Commission staff or otherwise relating thereto or to other accounting matters related
to initial public offering securities or expenses (collectively, the “SEC Statement”), (iii) filings required by applicable
state securities laws, (iv) the Required Approvals; (v) those required by The Nasdaq Capital Market (the “Nasdaq”)
or other applicable stock exchange on which the Securities are then listed, including with respect to obtaining approval of the Issuer’s
stockholders, and (vi) the failure of which to obtain would not be reasonably likely to have, individually or in the aggregate, an
Issuer Material Adverse Effect.

 

(f) Assuming
the accuracy of the Subscriber’s representations and warranties set forth in Section 4 of this Subscription Agreement, no
registration under the Securities Act is required for the offer and sale of the Securities by the Issuer to the Subscriber.

 

(g) Neither
the Issuer nor any person acting on its behalf has offered or sold the Securities by any form of general solicitation or general advertising
in violation of the Securities Act.

 

(h) The
Issuer is not under any obligation to pay any broker’s fee or commission in connection with the sale of the Securities other than
to the Agents (as defined below).

 

(i) As of
their respective filing dates or, if amended, as of the date of such amendment, which shall be deemed to supersede such original filing,
all reports required to be filed by the Issuer with the Commission (the “SEC Reports”) complied in all material respects
with the requirements of the Securities Act and the Securities Exchange Act of 1934, as amended (the “Exchange Act”),
and the rules and regulations of the Commission promulgated thereunder, and none of the SEC Reports filed under the Securities Act and
Exchange Act, contained, when filed or, if amended prior to the date of this Subscription Agreement, as of the date of such amendment
with respect to those disclosures that are amended, which shall be deemed to supersede such original filing, contained any untrue statement
of a material fact or omitted to state a material fact required to be stated therein or necessary to make the statements therein, in light
of the circumstances under which they were made, not misleading; provided, that notwithstanding anything to the contrary in this Subscription
Agreement, no representation or warranty is made under this Subscription Agreement or otherwise as to the accounting treatment of the
Issuer’s issued and outstanding warrants, other securities or any other initial public offering matter, or as to any deficiencies
in disclosure (including with respect to accounting and disclosure controls) arising therefrom, in any SEC Reports. The financial statements
of the Issuer included in the SEC Reports comply in all material respects with applicable accounting requirements and the rules and regulations
of the Commission with respect thereto as in effect at the time of filing, which shall be deemed to supersede such original filing, and
fairly present in all material respects the financial position of the Issuer as of and for the dates thereof and the results of operations
and cash flows for the periods then ended, subject, in the case of unaudited financial statements, to normal, year-end audit adjustments.
The Issuer has filed each periodic report that the Issuer was required to file with the Commission since February 18, 2021 and through
the date hereof. As of the date hereof, there are no material outstanding or unresolved comments in comment letters received by the Issuer
from the staff of the Division of Corporation Finance of the Commission with respect to any of the SEC Reports.

 

    4

     

    

 

(j) As of
the date hereof, the authorized share capital of Issuer consists of 100,000,000 Class A Shares, 10,000,000 Class B common stock, par value
$0.0001 per share (“Class B Shares”), and 1,000,000 shares of preferred stock, par value $0.0001 per share (“Preferred
Shares”). As of the date hereof: (i) 34,500,000 Class A Shares, 8,625,000 Class B Shares and no Preferred Shares were issued and
outstanding; and (ii) 8,625,000 public warrants, each exercisable to purchase one Class A Share at $11.50 per share (“Warrants”),
were issued and outstanding, as well as 6,266,667 private warrants. No Warrants are exercisable on or prior to the Closing.

 

(k) As of
the date hereof, the issued and outstanding Class A Shares of the Issuer are registered pursuant to Section 12(b) of the Exchange Act
and are listed for trading on the Nasdaq under the symbol “SCLE” (it being understood that the trading symbol will be changed
in connection with the Transactions). Except as disclosed in the SEC Reports, there is no suit, action, proceeding or investigation pending
or, to the knowledge of the Issuer, threatened against the Issuer by Nasdaq or the Commission, respectively, to prohibit or terminate
the listing of the Issuer’s shares on Nasdaq or to deregister the shares under the Exchange Act, excluding, for purposes of clarity,
the customary ongoing review by the Nasdaq of the Issuer’s continued listing application in connection with the Transactions. The
Issuer has taken no action that is designed to terminate the registration of the Issuer’s shares under the Exchange Act.

 

(l) The
Issuer is in compliance with all applicable laws, except where such noncompliance would not reasonably be expected to have, individually
or in the aggregate, an Issuer Material Adverse Effect. The Issuer has not received any written communication from a governmental entity
alleging that the Issuer is not in compliance with or is in default or violation of any applicable law, except where such noncompliance,
default or violation would not, individually or in the aggregate, reasonably be expected to have an Issuer Material Adverse Effect.

 

(m) Except
for such matters as would not reasonably be expected to have an Issuer Material Adverse Effect, the Issuer has not received any written
notice of any (i) suit, action, proceeding or arbitration before a governmental authority or arbitrator pending or threatened in writing
against the Issuer or (ii) judgment, decree, injunction, ruling or order of any governmental authority or arbitrator outstanding against
the Issuer. For the avoidance of doubt, this representation and warranty shall not apply to the extent any of the foregoing matters arise
from or relate to the SEC Statement.

 

(n) [The
Other Subscription Agreements reflect, with respect to the Class A Common Stock, a per Share purchase price and, if applicable, a proportion
of Warrants relative to such Subscriber’s purchase of Acquired Shares, in each case that are not materially more favorable to similarly
situated Other Investors thereunder than the terms of this Subscription Agreement, other than terms particular to the regulatory requirements
of such Other Investor or its affiliates or related funds. For the avoidance of doubt, this Section 3(n) shall not apply to (i) any document
entered into in connection with the Insider PIPE Investment, (ii) any document entered into in connection with the Strategic Investor
Investment or (iii) any document entered into with an Other Investor with respect to commercial or strategic arrangements not directly
related to the purchase of the Securities.]5

 

4. Subscriber
Representations and Warranties. Subscriber represents and warrants that:

 

(a) Subscriber
(i) has been duly formed or incorporated and is validly existing and in good standing under the laws of its jurisdiction of incorporation
or formation, and (ii) has the requisite power and authority to enter into, deliver and perform its obligations under this Subscription
Agreement.

 

(b) This
Subscription Agreement has been duly authorized, executed and delivered by Subscriber and assuming the due authorization, execution and
delivery of the same by the Issuer, this Subscription Agreement constitutes the valid and legally binding obligation of Subscriber, is
enforceable against it in accordance with its terms, except as such enforceability may be limited or otherwise affected by (i) bankruptcy,
insolvency, reorganization, fraudulent conveyance, arrangement, moratorium or other laws relating to or affecting the rights of creditors
generally, and (ii) principles of equity, whether considered at law or equity.

 

 

		5	Only included for investors subscribed for more than a certain
number of shares and certain other investors.

 

    5

     

    

 

 

(c) Assuming
the accuracy of the Issuer’s representations and warranties in Section 3, the execution, delivery and performance by Subscriber
of this Subscription Agreement, the purchase of the Securities and the compliance by Subscriber with all of the provisions of this Subscription
Agreement and the consummation of the transactions contemplated hereby, will not conflict with or result in a breach or violation of any
of the terms or provisions of, or constitute a default under, or result in the creation or imposition of any lien, charge or encumbrance
upon any of the property or assets of Subscriber or any of its subsidiaries pursuant to the terms of (i) any indenture, mortgage,
deed of trust, loan agreement, lease, license or other agreement or instrument to which Subscriber or any of its subsidiaries is a party
or by which Subscriber or any of its subsidiaries is bound or to which any of the property or assets of Subscriber or any of its subsidiaries
is subject; (ii) the organizational documents of Subscriber; or (iii) any statute or any judgment, order, rule or regulation
of any court or governmental agency or body, domestic or foreign, having jurisdiction over Subscriber or any of its subsidiaries or any
of their respective properties that, in the case of clauses (i) and (iii), would reasonably be expected to have a material adverse effect
on the legal authority or ability of Subscriber to perform in any material respects its obligations hereunder (a “Subscriber
Material Adverse Effect”).

 

(d) Subscriber
(i) is a “qualified institutional buyer” (as defined in Rule 144A under the Securities Act) or an institutional “accredited
investor” (within the meaning of Rule 501(a) under the Securities Act), and, in each case, satisfying the applicable requirements
set forth on Schedule A hereto, (ii) is acquiring the Securities only for its own account and not for the account of others,
or if Subscriber is subscribing for the Securities as a fiduciary or agent for one or more investor accounts, each owner of such account
is a “qualified institutional buyer” (as defined in Rule 144A under the Securities Act) or an institutional “accredited
investor” (within the meaning of Rule 501(a) under the Securities Act) and Subscriber has full investment discretion with respect
to each such account, and the full power and authority to make the acknowledgements, representations and agreements herein on behalf of
each owner of each such account, and (iii) is not acquiring the Securities with a view to, or for offer or sale in connection with,
any distribution thereof in violation of the Securities Act (and shall provide the requested information on Schedule A hereto).
Subscriber is not an entity formed for the specific purpose of acquiring the Securities and is an “institutional account”
as defined by FINRA Rule 4512(c), unless such newly formed entity is an entity in which all of the equity owners are “accredited
investors” (within the meaning of Rule 501(a) under the Securities Act).

 

(e) Subscriber
understands that the Securities are being offered in a transaction not involving any public offering within the meaning of the Securities
Act and that the Securities have not been registered under the Securities Act and that Issuer is not required to register the Securities
except as set forth in Section 5 of this Subscription Agreement. Subscriber understands that the Securities may not be offered,
resold, transferred, pledged or otherwise disposed of by Subscriber absent an effective registration statement under the Securities Act,
except (i) to the Issuer or a subsidiary thereof, (ii) to non-U.S. persons pursuant to offers and sales that occur in an “offshore
transaction” within the meaning of Regulation S under the Securities Act, (iii) pursuant to Rule 144 under the Securities Act,
provided that all of the applicable conditions thereof have been met (including, without limitation, those set forth in Rule 144(i)) or
(iv) pursuant to another applicable exemption from the registration requirements of the Securities Act, and, in each case, in accordance
with any applicable securities laws of the states of the United States and other applicable jurisdictions, and that any certificates or
book-entry records representing the Securities shall contain a legend to such effect. Subscriber acknowledges that the Securities will
not be eligible for resale pursuant to Rule 144A promulgated under the Securities Act. Subscriber understands and agrees that the Securities
will be subject to transfer restrictions and, as a result of these transfer restrictions, Subscriber may not be able to readily offer,
resell, transfer, pledge or otherwise dispose of the Securities and may be required to bear the financial risk of an investment in the
Securities for an indefinite period of time. Subscriber acknowledges and agrees that the Securities will not be eligible for offer, resale,
transfer, pledge or disposition pursuant to Rule 144 promulgated under the Securities Act (“Rule 144”) until at least
one year from the filing of “Form 10 information” with the Commission after the Closing Date. Subscriber understands that
it has been advised to consult legal, tax and accounting advisors prior to making any offer, resale, pledge, disposition or transfer of
any of the Securities.

 

    6

     

    

 

(f) Subscriber
understands and agrees that Subscriber is purchasing the Securities directly from the Issuer. Subscriber further acknowledges that there
have not been, and Subscriber hereby agrees that it is not relying on, any representations, warranties, covenants or agreements made to
Subscriber by or on behalf of the Issuer, the Target, the Agent, any of their respective affiliates or any control persons, officers,
directors, employees, partners, agents or representatives, any other party to the Transactions or any other person or entity, expressly
or by implication, other than those representations, warranties, covenants and agreements of the Issuer expressly set forth in this Subscription
Agreement [and, solely with respect to the Warrants, the Warrant Agreement,]6
and Subscriber is not relying on representations, warranties or any statement by, on behalf of or with respect to the Issuer except for
the representations and warranties set forth in Section 3 of this Subscription Agreement [and, solely with respect to the Warrants,
the Warrant Agreement]7. Subscriber acknowledges
that certain information provided to Subscriber was based on projections, and such projections were prepared based on assumptions and
estimates that are inherently uncertain and are subject to a wide variety of significant business, economic and competitive risks and
uncertainties that could cause actual results to differ materially from those contained in the projections.

 

(g) Subscriber
represents and warrants that its acquisition and holding of the Securities will not constitute or result in a non-exempt prohibited transaction
under section 406 of the Employee Retirement Income Security Act of 1974, as amended, section 4975 of the Internal Revenue Code of 1986,
as amended (the “Code”), or any
applicable similar law.

 

(h) Subscriber
is a sophisticated investor with extensive expertise and experience in financial and business matters and in evaluating companies and
purchasing and selling their securities. In making its decision to purchase the Securities, Subscriber represents that it has relied solely
upon the independent investigation made by Subscriber and has not relied on any statements or information provided by the Agents. Subscriber
acknowledges and agrees that Subscriber has received or had access to, and an adequate opportunity to review, such information as Subscriber
deems necessary in order to make an investment decision with respect to the Securities, including, without limitation, with respect to
the Issuer and the Transactions. Without limiting the generality of the foregoing, Subscriber acknowledges that it has reviewed the Issuer’s
filings with the Commission. Subscriber represents and agrees that Subscriber and Subscriber’s professional advisor(s), if any,
have had the full opportunity to ask such questions, receive such answers and obtain such information as Subscriber and such Subscriber’s
professional advisor(s), if any, have deemed necessary to make an investment decision with respect to the Securities. The Agents or any
of their respective directors, officers, employees, representatives or controlling persons has not made any independent investigation
with respect to the Issuer, the Securities or the completeness or accuracy of any information provided to the Subscriber and has not made
or makes any representation as to the Issuer or the quality or value of the Securities and the Agents and any of their respective affiliates
may have acquired nonpublic information with respect to the Issuer which Subscriber agrees need not be provided to it. The Subscriber
agrees that none of the Agents shall be liable to any Subscriber for any action heretofore or hereafter taken or omitted to be taken by
any of them in connection with the Subscriber’s purchase of the Securities.

 

(i) Subscriber
became aware of this offering of the Securities solely by means of direct contact between Subscriber and the Issuer, the Target or their
respective representatives or advisors or by means of contact from Morgan Stanley & Co. LLC (“Morgan Stanley”),
Nomura Securities International, Inc. (“Nomura”), and Moelis & Company, acting as placement agents for the Issuer
(together, the “Agents”), and
the Securities were offered to Subscriber solely by direct contact between Subscriber and the Issuer, the Target or their respective representatives
or advisors or by contact between Subscriber and the Agents. Subscriber did not become aware of this offering of the Securities, nor were
the Securities offered to Subscriber, by any other means. Subscriber acknowledges that the Securities (i) were not offered by any
form of general advertising or general solicitation, and (ii) are not being offered in a manner involving a public offering under, or
in a distribution in violation of, the Securities Act, or any state securities laws.

 

(j) Subscriber
acknowledges that it is aware that there are substantial risks incident to the purchase and ownership of the Securities, including, without
limitation, those set forth in the Issuer’s filings with the Commission. Subscriber has such knowledge and experience in financial
and business matters as to be capable of evaluating the merits and risks of an investment in the Securities, and Subscriber has had an
opportunity to seek, and has sought such accounting, legal, business and tax advice as Subscriber has considered necessary to make an
informed investment decision. Subscriber acknowledges that Subscriber shall be responsible for any of Subscriber’s tax liabilities
that may arise as a result of the transactions contemplated by this Subscription Agreement, and that neither Issuer nor the Target has
provided any tax advice or any other representation or guarantee regarding the tax consequences of the transactions contemplated by this
Subscription Agreement.

 

 

		6	Only included for investors who are being issued Closing Warrants.

		7	Only included for investors who are being issued Closing Warrants.

 

    7

     

    

 

(k) Alone,
or together with any professional advisor(s), Subscriber represents and acknowledges that Subscriber has adequately analyzed and fully
considered the risks of an investment in the Securities and determined that the Securities are a suitable investment for Subscriber and
that Subscriber is able at this time and in the foreseeable future to bear the economic risk of a total loss of Subscriber’s investment
in the Issuer. Subscriber acknowledges specifically that a possibility of total loss exists.

 

(l) Subscriber
understands and agrees that no federal or state agency has passed upon or endorsed the merits of the offering of the Securities or made
any findings or determination as to the fairness of this investment.

 

(m) Subscriber
represents and warrants that neither Subscriber nor any of its officers, directors, managers, managing members, general partners or any
other person acting in a similar capacity or carrying out a similar function is (i) a person or entity named on the List of Specially
Designated Nationals and Blocked Persons, the Executive Order 13599 List, the Foreign Sanctions Evaders List, the Sectoral Sanctions Identification
List, or any other similar list of sanctioned persons, each of which is administered by the U.S. Treasury Department’s Office of
Foreign Assets Control (“OFAC”),
or any other Executive Order issued by the President of the United States and administered by OFAC (collectively, “OFAC Lists”);
(ii) directly or indirectly owned or controlled by, or acting on behalf of, a person, that is named on an OFAC List; (iii) organized,
incorporated, established, located, resident or born in, or a citizen, national, or the government, including any political subdivision,
agency, or instrumentality thereof, of, Cuba, Iran, North Korea, Syria, Venezuela, the Crimea region of Ukraine, or any other country
or territory embargoed or subject to substantial trade restrictions by the United States; (iv) a Designated National as defined in
the Cuban Assets Control Regulations, 31 C.F.R. Part 515; or (v) a non-U.S. shell bank or providing banking services indirectly to
a non-U.S. shell bank (collectively, a “Prohibited
Investor”). Subscriber agrees to provide law enforcement agencies, if requested thereby, such records as required by
applicable law, provided that Subscriber is permitted to do so under applicable law. Subscriber represents that if it is a financial institution
subject to the Bank Secrecy Act (31 U.S.C. section 5311 et seq.) (the “BSA”),
as amended by the USA PATRIOT Act of 2001 (the “PATRIOT
Act”), and its implementing regulations (collectively, the “BSA/PATRIOT
Act”), that Subscriber maintains policies and procedures reasonably designed to comply with applicable obligations under
the BSA/PATRIOT Act. Subscriber also represents that, to the extent required, it maintains policies and procedures reasonably designed
to ensure compliance with OFAC-administered sanctions programs, including for the screening of its investors against the OFAC Lists. Subscriber
further represents and warrants that, to the extent required, it maintains policies and procedures reasonably designed to ensure that
the funds held by Subscriber and used to purchase the Securities were legally derived and were not obtained, directly or indirectly, from
a Prohibited Investor.

 

(n) If
Subscriber is or is acting on behalf of an employee benefit plan that is subject to Title I of the Employee Retirement Income Security
Act of 1974, as amended (“ERISA”),
a plan, an individual retirement account or other arrangement that is subject to section 4975 of the Code or an employee benefit plan
that is a governmental plan (as defined in section 3(32) of ERISA), a church plan (as defined in section 3(33) of ERISA), a non-U.S. plan
(as described in section 4(b)(4) of ERISA) or other plan that is not subject to the foregoing but may be subject to provisions under any
other federal, state, local, non-U.S. or other laws or regulations that are similar to such provisions of ERISA or the Code (collectively,
“Similar Laws”), or an entity
whose underlying assets are considered to include “plan assets” of any such plan, account or arrangement (each, a “Plan”)
subject to the fiduciary or prohibited transaction provisions of ERISA or section 4975 of the Code, Subscriber represents and warrants
that (i) neither the Issuer, nor any of its respective affiliates (the ”Transaction Parties”) has acted as
the Plan’s fiduciary, or has been relied on for advice, with respect to its decision to acquire and hold the Securities, and none
of the Transaction Parties shall at any time be relied upon as the Plan’s fiduciary with respect to any decision to acquire, continue
to hold or transfer the Securities; and (ii) the decision to invest in the Securities has been made at the recommendation or direction
of an “independent fiduciary” (“Independent
Fiduciary”) within the meaning of US Code of Federal Regulations 29 C.F.R. section 2510.3 21(c), as amended from time
to time (the “Fiduciary Rule”)
who is (1) independent of the Transaction Parties; (2) is capable of evaluating investment risks independently, both in general
and with respect to particular transactions and investment strategies (within the meaning of the Fiduciary Rule); (3) is a fiduciary (under
ERISA and/or section 4975 of the Code) with respect to Subscriber’s investment in the Securities and is responsible for exercising
independent judgment in evaluating the investment in the Securities; and (4) is aware of and acknowledges that (A) none of the
Transaction Parties is undertaking to provide impartial investment advice, or to give advice in a fiduciary capacity, in connection with
the purchaser’s or transferee’s investment in the Securities, and (B) the Transaction Parties have a financial interest
in the purchaser’s investment in the Securities on account of the fees and other remuneration they expect to receive in connection
with transactions contemplated by this Subscription Agreement.

 

    8

     

    

 

(o) Subscriber
has, and prior to the Funding Date will have, sufficient funds to pay the Purchase Price pursuant to Section 2(a).

 

(p) No
broker or finder is entitled to any brokerage or finder’s fee or commission payable by Subscriber solely in connection with the
sale of the Securities to Subscriber based on any arrangement entered into by or on behalf of Subscriber.

 

(q) No
disclosure or offering document has been prepared by the Agents in connection with the offer and sale of the Securities.

 

(r) None
of the Agents, nor any of their respective affiliates, nor any of their respective control persons, officers, directors, employees, agents
or representatives of any of the foregoing has made any independent investigation with respect to the Issuer, the Target or its subsidiaries
or any of their respective businesses, or the Securities or the accuracy, completeness or adequacy of any information supplied to Subscriber
by the Issuer.

 

(s) In
connection with the issuance and purchase of the Securities, none of the Agents nor any of their respective affiliates has acted as Subscriber’s
financial advisor or fiduciary.

 

(t) Subscriber
does not have, as of the date hereof, and during the 30-day period immediately prior to the date hereof such Subscriber has not entered
into, any “put equivalent position” as such term is defined in Rule 16a-1 under the Exchange Act or short sale positions with
respect to the securities of the Issuer. Notwithstanding the foregoing, in the case of a Subscriber that is a multi-managed investment
vehicle whereby separate portfolio managers manage separate portions of such Subscriber’s assets and the portfolio managers have
no direct knowledge of the investment decisions made by the portfolio managers managing other portions of such Subscriber’s assets,
the representation set forth above shall only apply with respect to the portion of assets managed by the portfolio manager that made the
investment decision to purchase the Securities covered by this Subscription Agreement.

 

(u) [Subscriber
is not a “foreign person” or a “foreign entity,” as defined in Section 721 of the Defense Production Act of 1950,
as amended, including, without limitation, all implementing regulations thereof (the “DPA”). Subscriber is not controlled
by a “foreign person,” as defined in the DPA. Subscriber does not permit any foreign person affiliated with Subscriber, whether
affiliated as a limited partner or otherwise, to obtain through Subscriber any of the following with respect to the Issuer or the Target:
(i) access to any “material nonpublic technical information” (as defined in the DPA) in the possession of the Issuer or the
Target; (ii) membership or observer rights on the board of directors or equivalent governing body of the Issuer or the Target or
the right to nominate an individual to a position on the board of directors or equivalent governing body of the Issuer or the Target;
(iii) any involvement, other than through the voting of shares, in the substantive decision-making of the Issuer or the Target regarding
(x) the use, development, acquisition, or release of any “critical technology” (as defined in the DPA), (y) the use, development,
acquisition, safekeeping, or release of “sensitive personal data” (as defined in the DPA) of U.S. citizens maintained or collected
by the Issuer or the Target, or (z) the management, operation, manufacture, or supply of “covered investment critical infrastructure”
(as defined in the DPA); or (iv) “control” (as defined in the DPA) of the Issuer or the Target.]8

 

 

		8	Not included for non-U.S. investors.

 

    9

     

    

 

(v) Subscriber
acknowledges and is aware that (i) the Agents are acting as the Issuer’s placement agent and (ii) Morgan Stanley and Nomura are
acting as financial advisors to the Target and/or its affiliates with respect to the Transaction and will receive compensation from the
Target and/or its affiliates for such services. Subscriber understands and acknowledges that Morgan Stanley’s and Nomura’s
respective roles as financial advisor to the Target and/or its affiliates may give rise to potential conflicts of interest or the appearance
thereof.

 

(w) Subscriber
acknowledges and agrees that Issuer continues to review the SEC Statement and its implications, including on the financial statements
and other information included in its filings with the Commission, and any restatement, revision or other modification of its filings
with the Commission relating to or arising from such review, any subsequent related agreements or other guidance from the Staff of the
Commission shall be deemed not material for purposes of this Subscription Agreement.

 

5. Registration
Rights.

 

(a) The
Issuer agrees that, no later than the later of (x) thirty (30) calendar days after the Closing Date or (y) if the Issuer’s 2021
audited financial statements are required to be included, ninety (90) calendar days following the Issuer’s most recent fiscal year
end (such date, the “Filing Date”),
the Issuer will submit to or file with the Commission (at the Issuer’s sole cost and expense) a registration statement (the “Registration
Statement”) registering the resale of the Acquired Shares [and Closing Warrants and the issuance and resale of the Class
A Shares issuable upon exercise of the Closing Warrants] 9
which are eligible for registration (determined as of two (2) business days prior to such submission or filing) [(the “Registrable
Securities”)]10, and the Issuer
shall use its commercially reasonable efforts to have the Registration Statement declared effective as soon as practicable after the filing
thereof, but no later than the earlier of (i) the 90th calendar day following the Closing Date if the Commission notifies the Issuer
that it will “review” the Registration Statement) and (ii) the 10th business day after the date the Issuer is notified
(orally or in writing, whichever is earlier) by the Commission that the Registration Statement will not be “reviewed” or will
not be subject to further review (such earlier date, the “Effectiveness
Date”); provided, however, that the Issuer’s obligations to include the Registrable Securities in the Registration
Statement are contingent upon Subscriber furnishing in writing to the Issuer such information regarding Subscriber or its permitted assigns,
the securities of the Issuer held by Subscriber and the intended method of disposition of the Registrable Securities as shall be reasonably
requested by the Issuer to effect the registration of the Registrable Securities, and Subscriber shall execute such documents in connection
with such registration as the Issuer may reasonably request that are customary of a selling stockholder in similar situations, including
providing that the Issuer shall be entitled to postpone and suspend the effectiveness or use of the Registration Statement as set forth
in Section 5(d) or otherwise permitted hereunder; provided that Subscriber shall not in connection with the foregoing be
required to execute any lock-up or similar agreement or otherwise be subject to any contractual restriction on the ability to transfer
the Registrable Securities. Any failure by the Issuer to file the Registration Statement by the Filing Date or to effect such Registration
Statement by the Effectiveness Date shall not otherwise relieve the Issuer of its obligations to file or effect the Registration Statement
as set forth above in this Section 5.

 

 

		9	Only included for investors who are being issued Closing Warrants.

		10	Only included for investors who are being issued Closing Warrants.
For investors who will not be issued the Closing Warrants, references herein to “Registrable Securities” are replaced with
references to “Acquired Shares.”

 

    10

     

    

 

(b) At
its expense the Issuer shall:

 

(i) except
for such times as the Issuer is permitted hereunder to suspend the use of the prospectus forming part of a Registration Statement, use
its commercially reasonable efforts to keep such registration, and any qualification, exemption or compliance under state securities laws
which the Issuer determines to obtain, continuously effective with respect to Subscriber, and to keep the applicable Registration Statement
or any subsequent shelf registration statement free of any material misstatements or omissions, until the earlier of the following: (i) Subscriber
ceases to hold any Registrable Securities, (ii) the date all Registrable Securities held by Subscriber may be sold without restriction
under Rule 144, including without limitation, any volume and manner of sale restrictions which may be applicable to affiliates under Rule
144 and without the requirement for the Issuer to be in compliance with the current public information required under Rule 144(c)(1) (or
Rule 144(i)(2), if applicable), (iii) the date that all Registrable Securities held by Subscriber may be sold pursuant to another exemption
from registration and (iv) two years from the Effectiveness Date of the Registration Statement. The period of time during which the Issuer
is required hereunder to keep a Registration Statement effective is referred to herein as the “Registration
Period”;

 

(ii) during
the Registration Period, advise Subscriber within five (5) business days:

 

		(A)	when a Registration Statement or any amendment thereto has been filed with the Commission and when such Registration Statement or
any post-effective amendment thereto has become effective;

 

		(B)	after it shall receive notice or obtain knowledge thereof, of any request by the Commission for amendments or supplements to any Registration
Statement or the prospectus included therein or for additional information;

 

		(C)	after it shall receive notice or obtain knowledge thereof, of the issuance by the Commission of any stop order suspending the effectiveness
of any Registration Statement or the initiation of any proceedings for such purpose;

 

		(D)	of the receipt by the Issuer of any notification with respect to the suspension of the qualification of the Registrable Securities
included therein for sale in any jurisdiction or the initiation or threatening of any proceeding for such purpose; and

 

		(E)	subject to the provisions in this Subscription Agreement, of the occurrence of any event that requires the making of any changes in
any Registration Statement or prospectus so that, as of such date, the statements therein are not misleading and do not omit to state
a material fact required to be stated therein or necessary to make the statements therein (in the case of a prospectus, in the light of
the circumstances under which they were made) not misleading.

 

Notwithstanding anything to the contrary set forth
herein, the Issuer shall not, when so advising Subscriber of such events, provide Subscriber with any material, nonpublic information
regarding the Issuer other than to the extent that providing notice to Subscriber of the occurrence of the events listed in (A) through
(E) above constitutes material, nonpublic information regarding the Issuer;

 

(iii) during
the Registration Period, use its commercially reasonable efforts to obtain the withdrawal of any order suspending the effectiveness of
any Registration Statement as soon as reasonably practicable;

 

(iv) during
the Registration Period, upon the occurrence of any event contemplated in Section 5(b)(ii)(E) above, except for such times as the
Issuer is permitted hereunder to suspend, and has suspended, the use of a prospectus forming part of a Registration Statement, the Issuer
shall use its commercially reasonable efforts to as soon as reasonably practicable prepare a post-effective amendment to such Registration
Statement or a supplement to the related prospectus, or file any other required document so that, as thereafter delivered to purchasers
of the Registrable Securities included therein, such prospectus will not include any untrue statement of a material fact or omit to state
any material fact necessary to make the statements therein, in the light of the circumstances under which they were made, not misleading;

 

    11

     

    

 

(v) during
the Registration Period, use its commercially reasonable efforts to cause all Acquired Shares to be listed on each securities exchange
or market, if any, on which the Class A Shares issued by the Issuer have been listed;

 

(vi) during
the Registration Period, use its commercially reasonable efforts to allow the Subscriber to review disclosure regarding the Subscriber
in the Registration Statement; and

 

(vii) during
the Registration Period, use its commercially reasonable efforts to take all other steps necessary to effect the registration of the Registrable
Securities required hereby.

 

(c) At such
times as the benefits of Rule 144 are available to stockholders of the Issuer, the Issuer agrees to use commercially reasonable efforts
to, for so long as Subscriber holds Securities: (i) make and keep public information available, as those terms are understood and defined
in Rule 144; and (ii) file with the Commission in a timely manner all reports and other documents required of the Issuer under the Securities
Act and the Exchange Act so long as the Issuer remains subject to such requirements and the filing of such reports and other documents
is required for the applicable provisions of Rule 144 to enable Subscriber to sell the Securities under Rule 144.

 

(d) Notwithstanding
anything to the contrary in this Subscription Agreement, the Issuer shall be entitled to delay or postpone the submission, filing or effectiveness
of the Registration Statement, and from time to time to require Subscriber not to sell under the Registration Statement or to suspend
the effectiveness thereof, if Issuer determines (i) that in order for the Registration Statement not to contain a material misstatement
or omission, (x) an amendment thereto would be needed to include information that would at that time not otherwise be required in a current,
quarterly, or annual report under the Exchange Act, (y) the negotiation or consummation of a transaction by the Issuer or its subsidiaries
is pending or an event has occurred, which negotiation, consummation or event that the Issuer’s board of directors reasonably believes,
upon the advice of legal counsel, would require additional disclosure by the Issuer in the Registration Statement of material information
that the Issuer has a bona fide business purpose for keeping confidential and the non-disclosure of which in the Registration Statement
would be expected, in the reasonable determination of the Issuer’s board of directors, upon the advice of legal counsel, to cause
the Registration Statement to fail to comply with applicable disclosure requirements, or (z) in the good faith judgment of the Issuer’s
board of directors, such submission, filing or effectiveness or use of such Registration Statement, would be detrimental to the Issuer,
and the Issuer’s board of directors concludes that such submission, filing or effectiveness should be delayed or postponed, or (ii)
to delay the submission, filing or initial effectiveness of, or suspend use of, a Registration Statement and such delay or suspension
arises out of, or is a result of, or is related to or is in connection with the SEC Statement or other accounting matters, or any related
disclosure or other matters (each such circumstance, a “Suspension
Event”); provided, however, that the Issuer may not delay or suspend the Registration Statement on more
than three occasions or for more than ninety (90) consecutive calendar days, or more than one hundred and twenty (120) total
calendar days, in each case during any twelve-month period. Upon receipt of any written notice from the Issuer of the happening of any
Suspension Event during the period that the Registration Statement is effective or if as a result of a Suspension Event the Registration
Statement or related prospectus contains any untrue statement of a material fact or omits to state any material fact required to be stated
therein or necessary to make the statements therein (in light of the circumstances under which they were made, in the case of the prospectus)
not misleading, Subscriber agrees that (i) it will immediately discontinue offers and sales of the Registrable Securities under the
Registration Statement (excluding, for the avoidance of doubt, sales conducted pursuant to Rule 144) until Subscriber receives copies
of a supplemental or amended prospectus (which the Issuer agrees to promptly prepare) that corrects the misstatement(s) or omission(s)
referred to above and receives notice that any post-effective amendment has become effective or unless otherwise notified by the Issuer
that it may resume such offers and sales, and (ii) it will maintain the confidentiality of any information included in such written
notice delivered by the Issuer unless otherwise required by law or subpoena. If so directed by the Issuer, Subscriber will deliver to
the Issuer or, in Subscriber’s sole discretion destroy, all copies of the prospectus covering the Registrable Securities in Subscriber’s
possession; provided, however, that this obligation to deliver or destroy all copies of the prospectus covering the Registrable
Securities shall not apply (i) to the extent Subscriber is required to retain a copy of such prospectus (a) in order to comply
with applicable legal, regulatory, self-regulatory or professional requirements or (b) in accordance with a bona fide pre-existing
document retention policy or (ii) to copies stored electronically on archival servers as a result of automatic data back-up.

    12

     

    

 

(e) Indemnification.

 

(i) The
Issuer agrees to indemnify, to the extent permitted by law, Subscriber (to the extent a seller under the Registration Statement), its
directors and officers and each person who controls Subscriber (within the meaning of the Securities Act), to the extent permitted by
law, against all losses, claims, damages, liabilities and reasonable and documented out of pocket expenses (including reasonable and documented
attorneys’ fees of one law firm) caused by any untrue or alleged untrue statement of material fact contained in any Registration
Statement, prospectus included in any Registration Statement (“Prospectus”)
or preliminary Prospectus or any amendment thereof or supplement thereto or any omission or alleged omission of a material fact required
to be stated therein or necessary to make the statements therein (in the case of a Prospectus, in the light of the circumstances under
which they were made) not misleading, except insofar as the same are caused by or contained in any information or affidavit so furnished
in writing to the Issuer by or on behalf of such Subscriber expressly for use therein.

 

(ii) In
connection with any Registration Statement in which a Subscriber is participating, such Subscriber shall furnish (or cause to be furnished)
to the Issuer in writing such information and affidavits as the Issuer reasonably requests for use in connection with any such Registration
Statement or Prospectus and, to the extent permitted by law, shall indemnify the Issuer, its directors and officers and each person who
controls the Issuer (within the meaning of the Securities Act) against any losses, claims, damages, liabilities and expenses (including
without limitation reasonable attorneys’ fees) resulting from any untrue or alleged untrue statement of material fact contained
or incorporated by reference in any Registration Statement, Prospectus or preliminary Prospectus or any amendment thereof or supplement
thereto or any omission or alleged omission of a material fact required to be stated therein or necessary to make the statements therein
(in the case of a Prospectus, in the light of the circumstances under which they were made) not misleading, but only to the extent that
such untrue statement or omission is contained in (or not contained in, in the case of an omission) any information or affidavit so furnished
in writing by or on behalf of such Subscriber expressly for use therein; provided, however, that the liability of each such
Subscriber shall be several and not joint and shall be in proportion to and limited to the net proceeds received by such Subscriber from
the sale of Registrable Securities giving rise to such indemnification obligation.

 

(iii) Any
person entitled to indemnification herein shall (1) give prompt written notice to the indemnifying party of any claim with respect to
which it seeks indemnification (provided that the failure to give prompt notice shall not impair any person’s right to indemnification
hereunder to the extent such failure has not prejudiced the indemnifying party) and (2) permit such indemnifying party to assume the defense
of such claim with counsel reasonably satisfactory to the indemnified party. If such defense is assumed, the indemnifying party shall
not be subject to any liability for any settlement made by the indemnified party without its consent (but such consent shall not be unreasonably
withheld). An indemnifying party who elects not to assume the defense of a claim shall not be obligated to pay the fees and expenses of
more than one counsel for all parties indemnified by such indemnifying party with respect to such claim, unless in the reasonable judgment
of legal counsel to any indemnified party a conflict of interest exists between such indemnified party and any other of such indemnified
parties with respect to such claim. No indemnifying party shall, without the consent of the indemnified party, consent to the entry of
any judgment or enter into any settlement which cannot be settled in all respects by the payment of money (and such money is so paid by
the indemnifying party pursuant to the terms of such settlement) or which settlement does not include as an unconditional term thereof
the giving by the claimant or plaintiff to such indemnified party of a release from all liability in respect to such claim or litigation.

 

    13

     

    

 

(iv) The
indemnification provided for under this Subscription Agreement shall remain in full force and effect regardless of any investigation made
by or on behalf of the indemnified party or any officer, director or controlling person of such indemnified party and shall survive the
transfer of securities.

 

(v) If
the indemnification provided under this Section 5(e) from the indemnifying party is unavailable or insufficient to hold harmless
an indemnified party in respect of any losses, claims, damages, liabilities and expenses referred to herein, then the indemnifying party,
in lieu of indemnifying the indemnified party, shall contribute to the amount paid or payable by the indemnified party as a result of
such losses, claims, damages, liabilities and expenses in such proportion as is appropriate to reflect the relative fault of the indemnifying
party and the indemnified party, as well as any other relevant equitable considerations. The relative fault of the indemnifying party
and indemnified party shall be determined by reference to, among other things, whether any action in question, including any untrue or
alleged untrue statement of a material fact or omission or alleged omission to state a material fact, was made by (or not made by, in
the case of an omission), or relates to information supplied by (or not supplied by, in the case of an omission), such indemnifying party
or indemnified party, and the indemnifying party’s and indemnified party’s relative intent, knowledge, access to information
and opportunity to correct or prevent such action. The amount paid or payable by a party as a result of the losses or other liabilities
referred to above shall be deemed to include, subject to the limitations set forth in Sections 5(e)(i), (ii) and (iii) above, any
legal or other fees, charges or expenses reasonably incurred by such party in connection with any investigation or proceeding. No person
guilty of fraudulent misrepresentation (within the meaning of Section 11(f) of the Securities Act) shall be entitled to contribution pursuant
to this Section 5(e)(v) from any person who was not guilty of such fraudulent misrepresentation.

 

6. Termination.
This Subscription Agreement shall terminate and be void and of no further force and effect, and all rights and obligations of the parties
hereunder shall terminate without any further liability on the part of any party in respect thereof, upon the earliest to occur of (a) such
date and time as the Merger Agreement is terminated in accordance with its terms, (b) upon the mutual written agreement of each of
the parties hereto and the Target to terminate this Subscription Agreement, and (c) September 30, 2022 if the closing of the Transactions
has not occurred on or before such date and Subscriber provides written notice electing to terminate this Subscription Agreement; provided,
that nothing herein will relieve any party from liability for any willful material breach hereof (including for the avoidance of doubt
Subscriber’s willful breach of Section 2(b)(i)(x) of this Subscription Agreement with respect to its representations and
warranties as of the Subscription Closing) prior to the time of termination, and each party will be entitled to any remedies at law or
in equity to recover losses, liabilities or damages arising from such willful breach. The Issuer shall promptly notify Subscriber in writing
of the termination of the Merger Agreement (other than such termination as a result of the closing thereunder).

 

7. Trust
Account Waiver. Subscriber acknowledges that the Issuer is a blank check company with the powers and privileges to effect a merger,
asset acquisition, reorganization or similar business combination involving the Issuer and one or more businesses or assets. Subscriber
further acknowledges that, as described in the Issuer’s prospectus relating to its initial public offering dated February 11, 2021
(the “Prospectus”) available at
www.sec.gov, substantially all of the Issuer’s assets consist of the cash proceeds of the Issuer’s initial public offering
and private placements of its securities, and substantially all of those proceeds have been deposited in a trust account (the “Trust
Account”) for the benefit of the Issuer, its public stockholders and the underwriters of its initial public offering.
Except with respect to interest earned on the funds held in the Trust Account that may be released to the Issuer to pay its tax obligations,
if any, the cash in the Trust Account may be disbursed only for the purposes set forth in the Prospectus. For and in consideration of
the Issuer entering into this Subscription Agreement, the receipt and sufficiency of which are hereby acknowledged, Subscriber, on behalf
of itself and its affiliates and representatives, hereby irrevocably waives any and all right, title and interest, or any claim of any
kind they have or may have in the future as a result of, or arising out of, this Subscription Agreement, in or to any monies held in the
Trust Account, and agrees not to seek recourse or make or bring any action, suit, claim or other proceeding against the Trust Account
as a result of, or arising out of, this Subscription Agreement, the transactions contemplated hereby or the Securities, regardless of
whether such claim arises based on contract, tort, equity or any other theory of legal liability; provided, that nothing in this
Section 7 shall be deemed to limit Subscriber’s right, title, interest or claim to the Trust Account by virtue of Subscriber’s
record or beneficial ownership of Class A Shares acquired by any means other than pursuant to this Subscription Agreement. Subscriber
acknowledges and agrees that it shall not have any redemption rights with respect to the Securities pursuant to the Issuer’s certificate
of incorporation in connection with the Transactions or any other business combination, any subsequent liquidation of the Trust Account
or the Issuer or otherwise. In the event Subscriber has any claim against the Issuer as a result of, or arising out of, this Subscription
Agreement, the transactions contemplated hereby or the Securities, it shall pursue such claim solely against the Issuer and its assets
outside the Trust Account and not against the Trust Account or any monies or other assets in the Trust Account.

 

    14

     

    

 

8. Issuer’s
Covenants. At the request of the holder of the Securities, the Issuer shall reasonably cooperate with the holder of the Securities,
and the holder of the Securities shall provide the Issuer with such certifications and other customary documentation, to effect the removal
of the legend described in Section 4(e), and for the Issuer to issue a certificate without such legend to the holder of the Securities
upon which it is stamped or issue to such holder by electronic delivery at the applicable balance account at The Depository Trust Company
(“DTC”), if (i) such Securities are sold pursuant to an effective registration statement under the Securities Act, (ii) such
sale, assignment or transfer of the Securities may be made without registration under the applicable requirements of the Securities Act,
(iii) the Securities are sold, assigned or transferred pursuant to Rule 144 or (iv) the Securities are eligible to be sold without restriction
under, and without the requirement for the Issuer to be in compliance with the current public information requirements of, Rule 144. The
Issuer shall be responsible for the fees of its transfer agent and all DTC fees associated with such issuance.

 

9. Miscellaneous.

 

(a) Subscriber
acknowledges that the Issuer, the Agents and the Target (each as a third party beneficiary with right of enforcement) will rely on the
acknowledgments, understandings, agreements, representations and warranties of Subscriber contained in this Subscription Agreement. Prior
to the Subscription Closing, Subscriber agrees to promptly notify the Issuer, the Agents and the Target if any of the acknowledgments,
understandings, agreements, representations and warranties set forth herein are no longer accurate in all material respects. Subscriber
acknowledges and agrees that each purchase by Subscriber of Class A Shares from Issuer will constitute a reaffirmation of the acknowledgments,
understandings, agreements, representations and warranties herein (as modified by any such notice) by Subscriber as of the time of such
purchase. Prior to the Subscription Closing, the Issuer agrees to promptly notify Subscriber, the Agents and the Target if it becomes
aware that any of the acknowledgments, understandings, agreements, representations and warranties of Issuer contained in this Subscription
Agreement are no longer accurate in all material respects.

 

(b) Each
of the Issuer, Subscriber, the Target and the Agents (each as a third party beneficiary with right of enforcement), is entitled to rely
upon this Subscription Agreement and is irrevocably authorized to produce this Subscription Agreement or a copy hereof to any interested
party in any administrative or legal proceeding or official inquiry with respect to the matters covered hereby.

 

(c) This
Subscription Agreement and any of Subscriber’s rights and obligations hereunder may not be transferred or assigned, except for an
assignment to any affiliate of Subscriber, without the prior consent of the Issuer, provided that such assignee(s) agrees in writing
to be bound by the terms hereof and completes Schedule A hereto. Upon such assignment by a Subscriber, the assignee(s) shall become
Subscriber hereunder and have the rights and obligations provided for herein to the extent of such assignment; provided that, in
the case of any such transfer or assignment, the initial party to this Subscription Agreement shall remain bound by its obligations under
this Subscription Agreement in the event that the transferee or assignee, as applicable, does not comply with its obligations to consummate
the purchase of Securities contemplated hereby. Neither this Subscription Agreement nor any rights that may accrue to the Issuer hereunder
or any of the Issuer’s obligations may be transferred or assigned other than pursuant to the Transactions.

 

    15

     

    

 

(d) Subscriber
hereby acknowledges and agrees that it will not, nor will any person acting at the Subscriber’s direction or pursuant to any understanding
with the Subscriber, directly or indirectly offer, sell, pledge, contract to sell, sell any option, engage in hedging activities or execute
any “short sales” as defined in Rule 200 of Regulation SHO under the Exchange Act (“Short Sales”), of the
Securities until the consummation of the Transactions (or such earlier termination of this Subscription Agreement in accordance with its
terms). For the avoidance of doubt, this Section 9(d) shall not apply to (i) any sale (including the exercise of any redemption
right) of securities of the Issuer (A) held by the Subscriber, its controlled affiliates or any person or entity acting on behalf
of the Subscriber or any of its controlled affiliates prior to the execution of this Subscription Agreement or (B) purchased by the
Subscriber, its controlled affiliates or any person or entity acting on behalf of the Subscriber or any of its controlled affiliates in
an open market transaction after the execution of this Subscription Agreement or (ii) ordinary course, non-speculative hedging
transactions. [Notwithstanding the foregoing, (a) nothing herein shall prohibit entities under common management or that share an investment
advisor with Subscriber (including Subscriber’s controlled affiliates and/or affiliates) from entering into any Short Sales and
(b) in the case of a Subscriber that is a multi-managed investment bank vehicle whereby separate portfolio managers manage separate portions
of such Subscriber’s assets, this Section 9(d) shall apply only with respect to the portion of assets managed by the portfolio manager
that made the investment decision to purchase the Securities covered by this Subscription Agreement.]11

 

(e) All
the agreements, representations and warranties made by each party hereto in this Subscription Agreement shall survive the Subscription
Closing.

 

(f) The
Issuer may request from Subscriber such additional information as the Issuer may deem reasonably necessary to evaluate the eligibility
of Subscriber to acquire the Securities and to comply with the Issuer’s obligations under Section 5 and Section 8
hereof, and Subscriber shall provide such information as may be reasonably requested, to the extent readily available and to the extent
consistent with its internal policies and procedures. Subscriber acknowledges that Issuer may file a copy of this Subscription Agreement
with the Commission as an exhibit to a current or periodic report or a registration statement of Issuer.

 

(g) This
Subscription Agreement may not be modified, waived or terminated (other than pursuant to the terms of Section 6 above) except by
an instrument in writing, signed by the party against whom enforcement of such modification, waiver, or termination is sought; provided,
however, that no modification, amendment or waiver by the Issuer of the provisions of this Subscription Agreement shall be effective
without the prior written consent of the Target to the extent required by the Merger Agreement. No failure or delay of either party in
exercising any right or remedy hereunder shall operate as a waiver thereof, nor shall any single or partial exercise of any such right
or power, or any abandonment or discontinuance of steps to enforce such right or power, or any course of conduct, preclude any other or
further exercise thereof or the exercise of any other right or power. The rights and remedies of the parties and third party beneficiaries
hereunder are cumulative and are not exclusive of any rights or remedies that they would otherwise have hereunder.

 

(h) This
Subscription Agreement (including the schedule hereto) constitutes the entire agreement, and supersedes all other prior agreements, understandings,
representations and warranties, both written and oral, among the parties, with respect to the subject matter hereof.

 

(i) Subject
to Section 9(c) and except as otherwise provided herein, this Subscription Agreement shall be binding upon, and inure to the benefit
of the parties hereto and their respective affiliates and their respective heirs, executors, administrators, successors, legal representatives,
and permitted assigns, and is not for the benefit of, nor may any provision hereof be enforced by, any other person. The agreements, representations,
warranties, covenants and acknowledgments contained herein shall be deemed to be made by, and be binding upon, such heirs, executors,
administrators, successors, legal representatives and permitted assigns.

 

(j) If
any provision of this Subscription Agreement shall be adjudicated by a court of competent jurisdiction to be invalid, illegal or unenforceable,
the validity, legality or enforceability of the remaining provisions of this Subscription Agreement shall not in any way be affected or
impaired thereby and shall continue in full force and effect.

 

(k) This
Subscription Agreement may be executed in one (1) or more counterparts (including by electronic means), all of which shall be considered
one and the same agreement and shall become effective when signed by each of the parties and delivered to the other parties, it being
understood that all parties need not sign the same counterpart.

 

 

		11	Only included for investors subscribed for more than a certain
number of shares and certain other investors.

 

    16

     

    

  

(l) Subscriber
shall pay all of its own expenses in connection with this Subscription Agreement and the transactions contemplated by this Subscription
Agreement.

 

(m) Except
as set forth in Sections 9(a), (b), (g) and (o), this Subscription Agreement shall not confer any rights or remedies upon
any person other than the parties hereto, and their respective successors and assigns; provided, that the parties acknowledge and
agree that the indemnified parties referred to therein shall each be a third-party beneficiary to this Subscription Agreement with respect
to Section 5(e)(i) and (ii), respectively.

 

(n) Any
notice or communication required or permitted hereunder shall be in writing and either delivered personally, emailed or by facsimile,
sent by overnight mail via a reputable overnight carrier, or sent by certified or registered mail, postage prepaid, and shall be deemed
to be given and received (a) when so delivered personally, (b) upon receipt of an appropriate electronic answerback or confirmation
when so delivered by facsimile (to such number specified below or another number or numbers as such person may subsequently designate
by notice given hereunder), (c) when sent, with no mail undeliverable or other rejection notice, if sent by email, or (d) five (5)
business days after the date of mailing to the address below or to such other address or addresses as such person may hereafter designate
by notice given hereunder:

 

(i) if
to Subscriber, to such address or addresses set forth on the signature page hereto;

 

(ii) if
to the Issuer, to:

 

1845 Walnut Street, Suite 1111

Philadelphia, PA 19103

Attention: Jeffrey F. Brotman

Telephone: (215) 832-4161

E-mail: jbrotman@hepcollc.com

 

with a required copy to (which copy shall not constitute notice)
each of:

 

Skadden, Arps, Slate, Meagher & Flom LLP

One Manhattan West

New York, NY 10001-8602

Attention: Howard Ellin and Mike Chitwood

Email: howard.ellin@skadden.com and mike.chitwood@skadden.com

 

Skadden, Arps, Slate, Meagher & Flom LLP

300 South Grand Avenue, Suite 3400

Los Angeles, CA 90071

Attention: Michelle Gasaway

Email: michelle.gasaway@skadden.com

 

(iii) if to the Target, to

 

Voltus, Inc.

2443 Fillmore Street, #308-3427

San Francisco, California 94115

Attention:       Gregg Dixon

                       Laurie Harrison

Email:             greggdixon@voltus.co

                       lharrison@voltus.co

 

with a required copy to (which copy shall not constitute notice):

 

Latham & Watkins LLP

811 Main Street, Suite 3700

Houston, TX 77002

Attention:       Ryan Maierson

                       Spencer Ricks

Email:             Ryan.Maierson@lw.com

                        Spencer.Ricks@lw.com

 

or to such other address or addresses as the parties
may from time to time designate in writing. Copies delivered solely to outside counsel shall not constitute notice.

 

    17

     

    

 

(o) The
parties hereto agree that irreparable damage would occur in the event that any of the provisions of this Subscription Agreement were not
performed in accordance with their specific terms or were otherwise breached. It is accordingly agreed that the parties shall be entitled
to an injunction or injunctions to prevent breaches of this Subscription Agreement and to enforce specifically the terms and provisions
of this Subscription Agreement, this being in addition to any other remedy to which such party is entitled at law, in equity, in contract,
in tort or otherwise. The parties hereto acknowledge and agree that the Target shall be entitled to seek to specifically enforce the provisions
of the Subscription Agreement of which the Target is an express third party beneficiary on the terms and subject to the conditions set
forth herein.

 

(p) This
Subscription Agreement, and any claim or cause of action hereunder based upon, arising out of or related to this Subscription Agreement
(whether based on law, in equity, in contract, in tort or any other theory) or the negotiation, execution, performance or enforcement
of this Subscription Agreement, shall be governed by and construed in accordance with the laws of the State of New York, without giving
effect to the principles of conflicts of laws that would otherwise require the application of the law of any other state.

 

THE PARTIES HERETO IRREVOCABLY SUBMIT TO THE EXCLUSIVE
JURISDICTION OF THE UNITED STATES DISTRICT COURT FOR THE SOUTHERN DISTRICT OF NEW YORK, THE SUPREME COURT OF THE STATE OF NEW YORK AND
THE FEDERAL COURTS OF THE UNITED STATES OF AMERICA LOCATED IN THE STATE OF NEW YORK SOLELY IN RESPECT OF THE INTERPRETATION AND ENFORCEMENT
OF THE PROVISIONS OF THIS SUBSCRIPTION AGREEMENT AND THE TRANSACTIONS CONTEMPLATED HEREBY, AND HEREBY WAIVE, AND AGREE NOT TO ASSERT,
AS A DEFENSE IN ANY ACTION, SUIT OR PROCEEDING FOR INTERPRETATION OR ENFORCEMENT HEREOF OR THAT SUCH ACTION, SUIT OR PROCEEDING MAY NOT
BE BROUGHT OR IS NOT MAINTAINABLE IN SAID COURTS OR THAT VENUE THEREOF MAY NOT BE APPROPRIATE OR THAT THIS SUBSCRIPTION AGREEMENT MAY
NOT BE ENFORCED IN OR BY SUCH COURTS, AND THE PARTIES HERETO IRREVOCABLY AGREE THAT ALL CLAIMS WITH RESPECT TO SUCH ACTION, SUIT OR PROCEEDING
SHALL BE HEARD AND DETERMINED BY SUCH A NEW YORK STATE OR FEDERAL COURT. THE PARTIES HEREBY CONSENT TO AND GRANT ANY SUCH COURT JURISDICTION
OVER THE PERSON OF SUCH PARTIES AND OVER THE SUBJECT MATTER OF SUCH DISPUTE AND AGREE THAT MAILING OF PROCESS OR OTHER PAPERS IN CONNECTION
WITH SUCH ACTION, SUIT OR PROCEEDING IN THE MANNER PROVIDED IN SECTION 9(n) OR IN SUCH OTHER MANNER AS MAY BE PERMITTED BY LAW
SHALL BE VALID AND SUFFICIENT SERVICE THEREOF.

 

EACH PARTY ACKNOWLEDGES AND AGREES THAT ANY
CONTROVERSY WHICH MAY ARISE UNDER THIS SUBSCRIPTION AGREEMENT OR THE TRANSACTIONS CONTEMPLATED HEREBY IS LIKELY TO INVOLVE COMPLICATED
AND DIFFICULT ISSUES, AND THEREFORE EACH SUCH PARTY HEREBY IRREVOCABLY AND UNCONDITIONALLY WAIVES ANY RIGHT SUCH PARTY MAY HAVE TO A TRIAL
BY JURY IN RESPECT OF ANY LITIGATION DIRECTLY OR INDIRECTLY ARISING OUT OF OR RELATING TO THIS SUBSCRIPTION AGREEMENT OR THE TRANSACTIONS
CONTEMPLATED BY THIS SUBSCRIPTION AGREEMENT. EACH PARTY CERTIFIES AND ACKNOWLEDGES THAT (I) NO REPRESENTATIVE, AGENT OR ATTORNEY
OF ANY OTHER PARTY HAS REPRESENTED, EXPRESSLY OR OTHERWISE, THAT SUCH OTHER PARTY WOULD NOT, IN THE EVENT OF LITIGATION, SEEK TO ENFORCE
THE FOREGOING WAIVER; (II) SUCH PARTY UNDERSTANDS AND HAS CONSIDERED THE IMPLICATIONS OF THE FOREGOING WAIVER; (III) SUCH PARTY
MAKES THE FOREGOING WAIVER VOLUNTARILY AND (IV) SUCH PARTY HAS BEEN INDUCED TO ENTER INTO THIS SUBSCRIPTION AGREEMENT BY, AMONG OTHER
THINGS, THE MUTUAL WAIVER AND CERTIFICATIONS IN THIS SECTION 9(p).

 

    18

     

    

 

(q) If,
any change in the Class A Shares or Warrants shall occur between the date hereof and immediately prior to the Subscription Closing by
reason of any reclassification, recapitalization, stock split (including reverse stock split) or combination, exchange or readjustment
of shares, or any stock dividend, the number of Acquired Shares and Closing Warrants issued to Subscriber shall be appropriately adjusted
to reflect such change.

 

(r) The
Issuer shall, by 9:00 a.m., New York City time, on the first (1st) Business Day immediately following the date of this Subscription Agreement,
issue one or more press releases or file or furnish with the Commission a Current Report on Form 8-K or a Form S-4 or proxy statement
for the Transaction (collectively, the “Disclosure Document”) disclosing, to the extent not previously disclosed, all material
terms of the transactions contemplated by this Subscription Agreement, the Other Subscription Agreements, the Insider Subscription Agreements,
the Transaction and any other material, nonpublic information that the Issuer has provided to Subscriber at any time prior to the filing
of the Disclosure Document. At the time of the disclosure of the Disclosure Document, to the Issuer’s knowledge, (i) Subscriber
shall not be in possession of any material, non-public information received from the Issuer or any of its affiliates, officers, directors,
employees or agents, and (ii) Subscriber shall no longer be subject to any confidentiality or similar obligations under any agreement,
whether written or oral, with the Issuer, the Agents, or any of their respective affiliates relating to the transactions contemplated
by this Subscription Agreement. All press releases or other public communications relating to the transactions contemplated hereby between
the Issuer and Subscriber, and the method of the release for publication thereof, shall be subject to the prior approval of (i) the Issuer,
and (ii) to the extent such press release or public communication references the Subscriber or its affiliates or investment advisers by
name, the Subscriber, which approval shall not be unreasonably withheld or conditioned; provided that neither the Issuer nor Subscriber
shall be required to obtain consent pursuant to this Section 9(r) to the extent any proposed release or statement is substantially
equivalent to the information that has previously been made public without breach of the obligation under this Section 9(r). The
restriction in this Section 9(r) shall not apply to the extent the public announcement is required by applicable securities law,
any governmental authority or stock exchange rule; provided, that in such an event, the applicable party shall use its commercially reasonable
efforts to consult with the other party in advance as to its form, content and timing. Subscriber will promptly provide any information
reasonably requested by the Issuer for any regulatory application or filing made or approval sought in connection with the Transaction
(including filings with the Commission).

 

[Signature pages follow]

 

    19

     

    

 

IN WITNESS WHEREOF, each of the Issuer and
Subscriber has executed or caused this Subscription Agreement to be executed by its duly authorized representative as of the date first
written above.

 

	 	BROADSCALE ACQUISITION CORP.
	 	 	                    
	 	By:	 
	 	Name:	 
	 	Title:	 

 

Signature Page to Subscription Agreement

 

    

     

    

 

 

	
     

    SUBSCRIBER:
	 
	 	 
	Signature of Subscriber:	Signature of Joint Subscriber, if applicable:
	 	 
	By: ___________________________________

Name:

Title:	By: ___________________________________

Name:

Title:

 

Date:  ___________________, 2021

	
     

    Signature of Subscriber:
	Signature of Joint Subscriber, if applicable:
	 	 
	___________________________________

(Please print. Please indicate name and

capacity of person signing above)	___________________________________

(Please print. Please indicate name and

capacity of person signing above)
	 	 
	___________________________________

Name in which securities are to be registered

(if different)	 
	 	 
	Email Address:	 
	 	 
	If there are joint investors, please check one:	 
	 	 
	☐ Joint Tenants with Rights of Survivorship	 
	 	 
	☐ Tenants-in-Common	 
	 	 
	☐ Community Property	 
	 	 
	Subscriber’s EIN:  _______________	Joint Subscriber’s EIN:

________________________________
	Business Address-Street:	Mailing Address-Street (if different):
	 	 
	___________________________________	___________________________________
	 	 
	___________________________________

City, State, Zip:	___________________________________

City, State, Zip:
	 	 
	Attn:	Attn:
	 	 
	Telephone No.: ___________________	Telephone No.: ___________________
	 	 
	Facsimile No.: ____________________	Facsimile No.: ____________________
	 	 
	Aggregate Number of Acquired Shares subscribed for:	[Aggregate Number of Closing Warrants subscribed for:
	
     

    ________________________________
	
     

    ________________________________]12

	 	 
	Purchase Price: $  _______________.	 

 

You must pay the Purchase Price by wire transfer of United States
dollars in immediately available funds to the account specified by the Issuer in the Closing Notice.

 

 

		12	Only included for investors who are being issued Closing Warrants.

 

Signature Page to Subscription Agreement

 

    

     

    

 

SCHEDULE A

ELIGIBILITY REPRESENTATIONS OF SUBSCRIBER

 

		A.	QUALIFIED INSTITUTIONAL BUYER STATUS

(Please check the applicable subparagraphs):

 

		1.	☐ We are a “qualified institutional buyer” (as defined
in Rule 144A under the Securities Act (a “QIB”)).

 

		2.	☐ We are subscribing for the Securities as a fiduciary or agent
for one or more investor accounts, and each owner of such account is a QIB.

 

*** OR ***

 

		B.	INSTITUTIONAL ACCREDITED INVESTOR STATUS

(Please check the applicable subparagraphs):

 

		1.	☐ We are an “accredited investor” (within the meaning
of Rule 501(a) under the Securities Act) or an entity in which all of the equity holders are accredited investors within the meaning of
Rule 501(a) under the Securities Act, and have marked and initialed the appropriate box on the following page indicating the provision
under which we qualify as an “accredited investor.”

 

		2.	☐ We are not a natural person.

 

*** AND ***

 

		C.	AFFILIATE STATUS

(Please check the applicable box)

 

SUBSCRIBER:

 

☐is:

 

☐is
not:

 

an “affiliate” (as defined in
Rule 144 under the Securities Act) of the Issuer or acting on behalf of an affiliate of the Issuer.

 

This page should be completed by Subscriber

and constitutes a part of the Subscription Agreement. 

 

    Schedule A-1

     

    

 

Rule 501(a), in relevant part, states that an “accredited investor”
shall mean any person who comes within any of the below listed categories, or who the Issuer reasonably believes comes within any of the
below listed categories, at the time of the sale of the securities to that person. Subscriber has indicated, by marking and initialing
the appropriate box below, the provision(s) below which apply to Subscriber and under which Subscriber accordingly qualifies as an “accredited
investor.”

 

☐
Any bank as defined in section 3(a)(2) of the Securities Act, or any savings and loan association or other institution as defined in section
3(a)(5)(A) of the Securities Act whether acting in its individual or fiduciary capacity;

 

☐
Any broker or dealer registered pursuant to section 15 of the Exchange Act;

 

☐
Any insurance company as defined in section 2(a)(13) of the Securities Act;

 

☐
Any investment company registered under the Investment Company Act of 1940 or a business development company as defined in section 2(a)(48)
of that Act;

 

☐
Any Small Business Investment Company licensed by the U.S. Small Business Administration under section 301(c) or (d) of the Small
Business Investment Act of 1958;

 

☐
Any plan established and maintained by a state, its political subdivisions, or any agency or instrumentality of a state or its political
subdivisions, for the benefit of its employees, if such plan has total assets in excess of $5,000,000;

 

☐
Any employee benefit plan within the meaning of the Employee Retirement Income Security Act of 1974 if the investment decision is made
by a plan fiduciary, as defined in section 3(21) of such Act, which is either a bank, savings and loan association, insurance company,
or registered investment adviser, or if the employee benefit plan has total assets in excess of $5,000,000 or, if a self-directed plan,
with investment decisions made solely by persons that are accredited investors;

 

☐
Any private business development company as defined in section 202(a)(22) of the Investment Advisers Act of 1940;

 

☐
Any organization described in section 501(c)(3) of the Internal Revenue Code, corporation, Massachusetts or similar business trust, or
partnership, not formed for the specific purpose of acquiring the securities offered, with total assets in excess of $5,000,000;

 

☐
Any trust, with total assets in excess of $5,000,000, not formed for the specific purpose of acquiring the securities offered, whose purchase
is directed by a sophisticated person as described in § 230.506(b)(2)(ii); or

 

☐ 
Any entity in which all of the equity owners are accredited investors meeting one or more of the above tests.

 

This page should be completed by Subscriber

and constitutes a part of the Subscription Agreement.

 

    Schedule A-2

     

    

 

EXHIBIT A13

 

CLOSING WARRANT AGREEMENT

 

[Attached]

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

		13	Only included for investors who are being issued Closing Warrants.

 

    Exhibit A-1

     

    

 

CLOSING WARRANT AGREEMENT

 

THIS CLOSING WARRANT AGREEMENT
(this “Agreement”), dated as of [●], 2021, is by and between Voltus Technologies, Inc., a Delaware corporation
(the “Company”), and Continental Stock Transfer & Trust Company, a New York corporation, as warrant agent
(the “Warrant Agent,” also referred to herein as the “Transfer Agent”).

 

WHEREAS, in connection with
the initial public offering of the Company (the “IPO”), the Company issued and delivered units (“IPO
Units”) to public investors comprised of one share of Class A common stock of the Company (the “Common Stock”)
and one-fourth of one redeemable warrant entitling the holder of such warrant to purchase one share of Class A common stock at an exercise
price of $11.50 per share (the “Public Warrants”), subject to adjustments as set forth in the Warrant Agreement
dates as of February 11, 2021 by and between the Company and the Warrant Agent (the “Public Warrant Agreement”);

 

WHEREAS, substantially concurrently
with the execution of this Agreement, the Company consummated the transactions contemplated by the Agreement and Plan of Merger, by and
among the Company, Velocity Merger Sub Inc., a Delaware corporation (“MergerSub”), and Voltus, Inc., a Delaware
corporation (“Target”) (the “Merger Agreement”), whereby MergerSub merged with and
into Target, with Target surviving as a wholly owned subsidiary of the Company, on the terms and subject to the conditions set forth therein
(the “Transaction”);

 

WHEREAS, to finance a portion
of the Transaction, the Company entered into separate subscription agreements with investors (such subscription agreements, the “Subscription
Agreements”), pursuant to which (i) the investors subscribed for Common Stock (the “Subscribed Shares”)
and (ii) certain key investors subscribed for Closing Warrants (as defined below) (and together with the Subscribed Shares, the “Securities”)
in a private placement (the “Private Placement”), and this Agreement is being entered into pursuant to the Subscription
Agreements with such key investors;

 

WHEREAS, an aggregate of 6,200,000
warrants are being issued and delivered to certain key investors pursuant to such Subscription Agreements which shall bear the legend
set forth in Exhibit B hereto (the “Closing Warrants”), each whole Closing Warrant entitling the holder
to purchase one share of Common Stock at an exercise price of $11.50 per share, subject to adjustment as described herein;

 

WHEREAS, the Company desires
the Warrant Agent to act on behalf of the Company, and the Warrant Agent is willing to so act, in connection with the issuance, registration,
transfer, exchange, redemption and exercise of the Closing Warrants;

 

WHEREAS, the Company desires
to provide for the form and provisions of the Closing Warrants, the terms upon which they shall be issued and exercised, and the respective
rights, limitation of rights, and immunities of the Company, the Warrant Agent and the holders of the Closing Warrants; and

 

WHEREAS, all acts and things
have been done and performed which are necessary to make the Closing Warrants, when executed on behalf of the Company and countersigned
by or on behalf of the Warrant Agent (if a physical certificate is issued), as provided herein, the valid, binding and legal obligations
of the Company, and to authorize the execution and delivery of this Agreement.

 

NOW, THEREFORE, in consideration
of the mutual agreements herein contained, the parties hereto agree as follows:

 

1. Appointment of Warrant
Agent.

 

The Company hereby appoints
Continental Stock Transfer & Trust Company to act as agent for the Company for the Closing Warrants, and Continental Stock Transfer
& Trust Company hereby accepts such appointment and agrees to perform the same in accordance with the terms and conditions set forth
in this Agreement.

 

2. Closing Warrants.

 

2.1 Form of Closing Warrant.
Each Closing Warrant shall initially be issued in registered form only. Physical certificates, if issued, shall be signed by, or bear
the facsimile signature of, the Chairman of the Board, Chief Executive Officer, Chief Financial Officer, Secretary or other principal
officer of the Company. In the event the person whose facsimile signature has been placed upon any Closing Warrant shall have ceased to
serve in the capacity in which such person signed the Closing Warrant before such Closing Warrant is issued, it may be issued with the
same effect as if he or she had not ceased to be such at the date of issuance.

 

2.2 Effect of Countersignature.
If a physical certificate is issued, unless and until countersigned by the Warrant Agent pursuant to this Agreement, a Closing Warrant
certificate shall be invalid and of no effect and may not be exercised by the holder thereof.

 

    Exhibit A-2

     

    

 

2.3 Registration.

 

2.3.1 Warrant Register.
The Warrant Agent shall maintain books (the “Warrant Register”) for the registration of original issuance and
the registration of transfer of the Closing Warrants. Upon the initial issuance of the Closing Warrants, the Warrant Agent shall issue
and register the Closing Warrants in the names of the respective holders thereof in such denominations and otherwise in accordance with
instructions delivered to the Warrant Agent by the Company. If the Closing Warrants become eligible for book-entry at the Depository Trust
Company (the “Depository”), they will be represented by one or more book-entry certificates (each, a “Book-Entry
Warrant Certificate”) deposited with the Depository and registered in the name of Cede & Co., a nominee of the Depositary,
and in such case, ownership of beneficial interests in the Closing Warrants shall be shown on, and the transfer of such ownership shall
be effected through, records maintained by institutions that have accounts with the Depository (each such institution, with respect to
a Closing Warrant in its account, a “Participant”).

 

If the Depositary subsequently
ceases to make its book-entry settlement system available for the Closing Warrants, the Company may instruct the Warrant Agent regarding
making other arrangements for book-entry settlement. In the event that the Closing Warrants are not eligible for, or it is no longer necessary
to have the Closing Warrants available in, book-entry form, the Warrant Agent shall provide written instructions to the Depositary to
deliver to the Warrant Agent for cancellation each Book-Entry Warrant Certificate, and the Company shall instruct the Warrant Agent to
deliver to or upon the order of the Depositary definitive warrant certificates in physical form evidencing such Closing Warrants. If any
Closing Warrants are evidenced by definitive certificates (“Definitive Warrant Certificates”), such Definitive
Warrant Certificates shall be in the form annexed hereto as Exhibit A.

 

2.3.2 Registered Holder.
Prior to due presentment for registration of transfer of any Closing Warrant, the Company and the Warrant Agent may deem and treat the
person in whose name such Closing Warrant is registered in the Warrant Register (the “Registered Holder”) as
the absolute owner of such Closing Warrant and of each Closing Warrant represented thereby (notwithstanding any notation of ownership
or other writing on any Definitive Warrant Certificate made by anyone other than the Company or the Warrant Agent), for the purpose of
any exercise thereof, and for all other purposes, and neither the Company nor the Warrant Agent shall be affected by any notice to the
contrary.

 

2.4 No Fractional Warrants.
The Company shall not issue fractional Closing Warrants. If a holder of Closing Warrants would be entitled to receive a fractional Closing
Warrant, the Company shall round down to the nearest whole number the number of Closing Warrants to be issued to such holder.

 

3. Terms and Exercise of
Closing Warrants.

 

3.1 Closing Warrant Price.
Each whole Closing Warrant shall entitle the Registered Holder thereof, subject to the provisions of such Closing Warrant and of this
Agreement, to purchase from the Company the number of shares of Common Stock stated therein, at the price of $11.50 per share, subject
to the adjustments provided in Section 4 hereof and in the last sentence of this Section 3.1. The term “Warrant
Price” as used in this Agreement shall mean the price per share (including in cash or by payment of Closing Warrants pursuant
to a “cashless exercise,” to the extent permitted hereunder) at which shares of Common Stock may be purchased at the time
a Closing Warrant is exercised. The Company in its sole discretion may lower the Warrant Price at any time prior to the Expiration Date
(as defined below) for a period of not less than twenty (20) Business Days (unless otherwise required by the Commission, any national
securities exchange on which the Closing Warrants are listed or applicable law); provided, that the Company shall provide at least
three (3) Business Days prior written notice of such reduction to Registered Holders of the Closing Warrants and, provided further that
any such reduction shall be identical among all of the Closing Warrants.

 

3.2 Duration of Closing Warrants.
A Closing Warrant may be exercised only during the period (the “Exercise Period”) commencing on the later of:
(i) the date that is thirty (30) days after the first date on which the Company completes a merger, capital stock exchange, asset acquisition,
stock purchase, reorganization or similar business combination, involving the Company and one or more businesses (a “Business
Combination”), and (ii) the date that is twelve (12) months from the date of the closing of the IPO, and terminating at
5:00 p.m., New York City time, on the earlier to occur of: (x) the date that is five (5) years after the date on which the Company completes
its initial Business Combination, (y) the commencement of the winding up and liquidation of the Company in accordance with the Company’s
amended and restated certificate of incorporation, as amended from time to time, if the Company fails to complete a Business Combination,
or (z) the Redemption Date (as defined below) as provided in Section 6.3 hereof (the “Expiration Date”);
provided, however, that the exercise of any Closing Warrant shall be subject to the satisfaction of any applicable conditions,
as set forth in subsection 3.3.2 below with respect to an effective registration statement or a valid exemption therefrom being
available. Except with respect to the right to receive the Redemption Price (as defined below), each outstanding Closing Warrant not exercised
on or before the Expiration Date shall become void, and all rights thereunder and all rights in respect thereof under this Agreement shall
cease at 5:00 p.m., New York City time, on the Expiration Date. The Company in its sole discretion may extend the duration of the Closing
Warrants by delaying the Expiration Date; provided, that the Company shall provide at least twenty (20) days prior written notice
of any such extension to Registered Holders of the Closing Warrants and, provided further that any such extension shall be identical in
duration among all the Closing Warrants.

 

    Exhibit A-3

     

    

 

3.3 Exercise of Closing Warrants.

 

3.3.1 Payment. Subject
to the provisions of the Closing Warrant and this Agreement, a Closing Warrant may be exercised by the Registered Holder thereof by delivering
to the Warrant Agent at its corporate trust department (i) the Definitive Warrant Certificate evidencing the Closing Warrants to be exercised,
or, in the case of a Book-Entry Warrant Certificate, the Closing Warrants to be exercised (the “Book-Entry Warrants”)
on the records of the Depositary, to an account of the Warrant Agent at the Depositary designated for such purposes in writing by the
Warrant Agent to the Depositary from time to time, (ii) an election to purchase (“Election to Purchase”) any
shares of Common Stock pursuant to the exercise of a Closing Warrant, properly completed and executed by the Registered Holder on the
reverse of the Definitive Warrant Certificate or, in the case of a Book-Entry Warrant, properly delivered by the Participant in accordance
with the Depositary’s procedures, and (iii) the payment in full of the Warrant Price for each full share of Common Stock as to which
the Closing Warrant is exercised and any and all applicable taxes due in connection with the exercise of the Closing Warrant, the exchange
of the Closing Warrant for the shares of Common Stock and the issuance of such shares of Common Stock, as follows:

 

(a) in lawful money of the United
States, by certified check payable to the order of the Warrant Agent or by wire transfer;

 

(b) so long as such Closing
Warrant is held by the original purchasers thereof or their Permitted Transferees, as applicable, by surrendering the Closing Warrants
for that number of shares of Common Stock equal to the quotient obtained by dividing (x) the product of the number of shares of Common
Stock underlying the Closing Warrants, multiplied by the excess of the “Fair Market Value”, as defined in this subsection
3.3.1(c), over the Warrant Price by (y) the Fair Market Value. Solely for purposes of this subsection 3.3.1(c), (1) the “Fair
Market Value” shall mean the average of the last reported sale prices of the Common Stock for the ten (10) trading days
ending on the third trading day prior to the date on which notice of exercise of the Warrant is received by the Warrant Agent and (2)
the “Permitted Transferees” shall mean such transferees in the event of transfer:

 

(A) to the original purchaser’s
officers or directors, any affiliates or family members of any of the original purchaser’s officers or directors, or any affiliates
of the original purchaser;

 

(B) in the case of an individual,
by gift to a member of such individual’s immediate family or to a trust, the beneficiary of which is a member of such individual’s
immediate family, an affiliate of such individual or to a charitable organization;

 

(C) in the case of an individual,
by virtue of the laws of descent and distribution upon death of such individual; or

 

(D) in the case of an individual,
pursuant to a qualified domestic relations order;

 

(c) as provided in Section
6.2 hereof with respect to a Make-Whole Exercise; and

 

(d) as provided in Section
7.4 hereof.

 

3.3.2 Issuance of Shares
of Common Stock upon Exercise. As soon as practicable after the exercise of any Closing Warrant and the clearance of the funds in
payment of the Warrant Price (if payment is pursuant to subsection 3.3.1(a)), the Company shall issue to the Registered Holder
of such Closing Warrant a book-entry position or certificate, as applicable, for the number of full shares of Common Stock to which he,
she or it is entitled, registered in such name or names as may be directed by him, her or it, and if such Closing Warrant shall not have
been exercised in full, a new book-entry position or countersigned Closing Warrant, as applicable, for the number of shares of Common
Stock as to which such Closing Warrant shall not have been exercised. Notwithstanding the foregoing and subject to the Company satisfying
its obligations in Section 7.4, the Company shall not be obligated to deliver any shares of Common Stock pursuant to the exercise of a
Closing Warrant and shall have no obligation to settle such Closing Warrant exercise unless a registration statement under the Securities
Act with respect to the shares of Common Stock underlying the Closing Warrants is then effective and a prospectus relating thereto is
current, or a valid exemption from registration is available. No Closing Warrant shall be exercisable and the Company shall not be obligated
to issue shares of Common Stock upon exercise of a Closing Warrant unless the Common Stock issuable upon such Closing Warrant exercise
has been registered, qualified or deemed to be exempt from registration or qualification under the securities laws of the state of residence
of the Registered Holder of the Closing Warrants. In the event that the conditions in the two immediately preceding sentences are not
satisfied with respect to a Closing Warrant, the holder of such Closing Warrant shall not be entitled to exercise such Closing Warrant
and such Closing Warrant may have no value and expire worthless. In no event will the Company be required to net cash settle the exercise
of any Closing Warrant. The Company may require holders of Closing Warrants to settle the Closing Warrant on a “cashless basis”
pursuant to Section 6.2 and Section 7.4 hereof. If, by reason of any exercise of Closing Warrants on a “cashless basis”,
the holder of any Closing Warrant would be entitled, upon the exercise of such Closing Warrant, to receive a fractional interest in a
share of Common Stock, the Company shall round down to the nearest whole number, the number of shares of Common Stock to be issued to
such holder.

 

    Exhibit A-4

     

    

 

3.3.3 Valid Issuance.
All shares of Common Stock issued upon the proper exercise of a Closing Warrant in conformity with this Agreement shall be validly issued,
fully paid and non-assessable.

 

3.3.4 Date of Issuance.
Each person in whose name any book-entry position or certificate, as applicable, for shares of Common Stock is issued shall for all purposes
be deemed to have become the holder of record of such shares of Common Stock on the date on which the Closing Warrant, or book-entry position
representing such Closing Warrant, was surrendered and payment of the Warrant Price was made, irrespective of the date of delivery of
such certificate in the case of a certificated Closing Warrant, except that, if the date of such surrender and payment is a date when
the share transfer books of the Company or book-entry system of the Warrant Agent are closed, such person shall be deemed to have become
the holder of such shares of Common Stock at the close of business on the next succeeding date on which the share transfer books or book-entry
system are open.

 

3.3.5 Maximum Percentage.
A holder of a Closing Warrant may notify the Company in writing in the event he, she or it elects to be subject to the provisions contained
in this subsection 3.3.5; however, no holder of a Closing Warrant shall be subject to this subsection 3.3.5 unless
he, she or it makes such election. If the election is made by a holder, the Warrant Agent shall not effect the exercise of the holder’s
Closing Warrant, and such holder shall not have the right to exercise such Closing Warrant, to the extent that after giving effect to
such exercise, such holder (together with such holder’s affiliates or any other person subject to aggregation with such person for
purposes of the “beneficial ownership” test under Section 13 of the Securities Exchange Act of 1934, as amended (the “Exchange
Act”), or any “group” (within the meaning of Section 13 of the Exchange Act) of which such person is or may
be deemed to be a part), to the Warrant Agent’s actual knowledge, would beneficially own (within the meaning of Section 13 of the
Exchange Act) (or to the extent that for any reason the equivalent calculation under Section 16 of the Exchange Act and the rules and
regulations thereunder would result in a higher ownership percentage, such higher percentage would be) in excess of 4.9% or 9.8% (or such
other amount as a holder may specify) (the “Maximum Percentage”) of the shares of Common Stock outstanding immediately
after giving effect to such exercise. For purposes of the foregoing sentence, the aggregate number of shares of Common Stock beneficially
owned by such holder and his, her or its affiliates or any such other person or group shall include the number of shares of Common Stock
issuable upon exercise of the Closing Warrant with respect to which the determination of such sentence is being made, but shall exclude
shares of Common Stock that would be issuable upon (x) exercise of the remaining, unexercised portion of the Closing Warrant beneficially
owned by such holder and his, her or its affiliates and (y) exercise or conversion of the unexercised or unconverted portion of any other
securities of the Company beneficially owned by such holder and his, her or its affiliates (including, without limitation, any convertible
notes or convertible preferred stock or warrants) subject to a limitation on conversion or exercise analogous to the limitation contained
herein. Except as set forth in the preceding sentence, for purposes of this paragraph, beneficial ownership shall be calculated in accordance
with Section 13(d) of the Exchange Act. For purposes of the Closing Warrant, in determining the number of outstanding shares of Common
Stock, the holder may rely on the number of outstanding shares of Common Stock as reflected in (1) the Company’s most recent Annual
Report on Form 10-K, Quarterly Report on Form 10-Q, Current Report on Form 8-K or other public filing with the Commission as the case
may be, (2) a more recent public announcement by the Company or (3) any other notice by the Company or the Transfer Agent setting forth
the number of shares of Common Stock outstanding. For any reason at any time, upon the written request of the holder of the Closing Warrant,
the Company shall, within two (2) Business Days, confirm orally and in writing to such holder the number of shares of Common Stock then
outstanding. In any case, the number of outstanding shares of Common Stock shall be determined after giving effect to the conversion or
exercise of equity securities of the Company by the holder and his, her or its affiliates since the date as of which such number of outstanding
shares of Common Stock was reported. By written notice to the Company, the holder of a Closing Warrant may from time to time increase
or decrease the Maximum Percentage applicable to such holder to any other percentage specified in such notice; provided, however,
that any such increase shall not be effective until the sixty-first (61st) day after such notice is delivered to the Company.

 

    Exhibit A-5

     

    

 

4. Adjustments.

 

4.1 Stock Dividends.

 

4.1.1 Split-Ups. If
after the date hereof, and subject to the provisions of Section 4.6 below, the number of outstanding shares of Common Stock is
increased by a stock dividend payable in shares of Common Stock, or by a split-up of shares of Common Stock or other similar event, then,
on the effective date of such stock dividend, split-up or similar event, the number of shares of Common Stock issuable on exercise of
each Closing Warrant shall be increased in proportion to such increase in the outstanding shares of Common Stock. A rights offering to
holders of the Common Stock entitling holders to purchase shares of Common Stock at a price less than the “Fair Market Value”
(as defined below) shall be deemed a stock dividend of a number of shares of Common Stock equal to the product of (i) the number of shares
of Common Stock actually sold in such rights offering (or issuable under any other equity securities sold in such rights offering that
are convertible into or exercisable for the Common Stock) and (ii) one (1) minus the quotient of (x) the price per share of Common Stock
paid in such rights offering divided by (y) the Fair Market Value. For purposes of this subsection 4.1.1, (i) if the rights offering
is for securities convertible into or exercisable for Common Stock, in determining the price payable for Common Stock, there shall be
taken into account any consideration received for such rights, as well as any additional amount payable upon exercise or conversion and
(ii) “Fair Market Value” means the volume weighted average price of the Common Stock as reported during the ten (10) trading
day period ending on the trading day prior to the first date on which the shares of Common Stock trade on the applicable exchange or in
the applicable market, regular way, without the right to receive such rights.

 

4.1.2 Extraordinary Dividends.
If the Company, at any time while the Closing Warrants are outstanding and unexpired, shall pay a dividend or make a distribution in cash,
securities or other assets to the holders of the Common Stock on account of such shares of Common Stock (or other shares of the Company’s
capital stock into which the Closing Warrants are convertible), other than (a) as described in subsection 4.1.1 above or (b) Ordinary
Cash Dividends (as defined below) (any such non-excluded event being referred to herein as an “Extraordinary Dividend”),
then the Warrant Price shall be decreased, effective immediately after the effective date of such Extraordinary Dividend, by the amount
of cash and/or the fair market value (as determined by the Company’s Board of Directors (the “Board”),
in good faith) of any securities or other assets paid on each share of Common Stock in respect of such Extraordinary Dividend. For purposes
of this subsection 4.1.2, “Ordinary Cash Dividends” means any cash dividend or cash distribution which,
when combined on a per share basis, with the per share amounts of all other cash dividends and cash distributions paid on the Common Stock
during the 365-day period ending on the date of declaration of such dividend or distribution (as adjusted to appropriately reflect any
of the events referred to in other subsections of this Section 4 and excluding cash dividends or cash distributions that resulted
in an adjustment to the Warrant Price or to the number of shares of Common Stock issuable on exercise of each Closing Warrant) does not
exceed $0.50 (being 5% of the offering price of the Securities in the Private Placement). Solely for purposes of illustration, if the
Company, at a time while the Closing Warrants are outstanding and unexpired, pays a cash dividend of $0.35 per share and previously paid
an aggregate of $0.40 of cash dividends and cash distributions on the shares of Common Stock during the 365-day period ending on the date
of declaration of such $0.35 per share dividend, then the Warrant Price will be decreased, effective immediately after the effective date
of such $0.35 per share dividend, by $0.25 (the absolute value of the difference between $0.75 per share (the aggregate amount of all
cash dividends and cash distributions paid or made in such 365- day period, including such $0.35 dividend) and $0.50 per share (the greater
of (x) $0.50 per share and (y) the aggregate amount of all cash dividends and cash distributions paid or made in such 365-day period prior
to such $0.35 dividend)).

 

4.2 Aggregation of Shares.
If after the date hereof, and subject to the provisions of Section 4.6 hereof, the number of outstanding shares of Common Stock
is decreased by a consolidation, combination, reverse stock split or reclassification of shares of Common Stock or other similar event,
then, on the effective date of such consolidation, combination, reverse stock split, reclassification or similar event, the number of
shares of Common Stock issuable on exercise of each Closing Warrant shall be decreased in proportion to such decrease in outstanding shares
of Common Stock.

 

4.3 Adjustments in Warrant
Price.

 

4.3.1 Whenever the number
of shares of Common Stock purchasable upon the exercise of the Closing Warrants is adjusted, as provided in subsection 4.1.1 or
Section 4.2 above, the Warrant Price shall be adjusted (to the nearest cent) by multiplying such Warrant Price immediately prior
to such adjustment by a fraction (x) the numerator of which shall be the number of shares of Common Stock purchasable upon the exercise
of the Closing Warrants immediately prior to such adjustment, and (y) the denominator of which shall be the number of shares of Common
Stock so purchasable immediately thereafter.

 

    Exhibit A-6

     

    

 

4.3.2 In the event that the
exercise price of the Public Warrants is adjusted as a result of section 4.3.2 of the Public Warrant Agreement, the Warrant Price shall
have a one-time adjustment to equal the same exercise price as the Public Warrants.

 

4.4 Replacement of Securities
upon Reorganization, etc. In case of any reclassification or reorganization of the outstanding shares of Common Stock (other than
a change under subsections 4.1.1 or 4.1.2 or Section 4.2 hereof or that solely affects the par value of such shares
of Common Stock), or in the case of any merger or consolidation of the Company with or into another entity or conversion of the Company
as another entity (other than a consolidation or merger in which the Company is the continuing corporation and that does not result in
any reclassification or reorganization of the outstanding shares of Common Stock), or in the case of any sale or conveyance to another
corporation or entity of the assets or other property of the Company as an entirety or substantially as an entirety in connection with
which the Company is dissolved, the holders of the Closing Warrants shall thereafter have the right to purchase and receive, upon the
basis and upon the terms and conditions specified in the Closing Warrants and in lieu of the shares of Common Stock of the Company immediately
theretofore purchasable and receivable upon the exercise of the rights represented thereby, the kind and amount of shares of stock or
other securities or property (including cash) receivable upon such reclassification, reorganization, merger or consolidation, or upon
a dissolution following any such sale or transfer, that the holder of the Closing Warrants would have received if such holder had exercised
his, her or its Closing Warrant(s) immediately prior to such event (the “Alternative Issuance” ); provided,
however, that (i) if the holders of the Common Stock were entitled to exercise a right of election as to the kind or amount of
securities, cash or other assets receivable upon such consolidation or merger, then the kind and amount of securities, cash or other assets
constituting the Alternative Issuance for which each Closing Warrant shall become exercisable shall be deemed to be the weighted average
of the kind and amount received per share by the holders of the Common Stock in such consolidation or merger that affirmatively make such
election, and (ii) if a tender, exchange or redemption offer shall have been made to and accepted by the holders of the Common Stock (other
than a tender, exchange or redemption offer made by the Company in connection with redemption rights held by stockholders of the Company
as provided for in the Company’s amended and restated certificate of incorporation or as a result of the repurchase of shares of
Common Stock by the Company if a proposed initial Business Combination is presented to the stockholders of the Company for approval) under
circumstances in which, upon completion of such tender or exchange offer, the maker thereof, together with members of any group (within
the meaning of Rule 13d-5(b)(1) under the Exchange Act (or any successor rule)) of which such maker is a part, and together with any affiliate
or associate of such maker (within the meaning of Rule 12b-2 under the Exchange Act (or any successor rule)) and any members of any such
group of which any such affiliate or associate is a part, own beneficially (within the meaning of Rule 13d-3 under the Exchange Act (or
any successor rule)) more than 50% of the outstanding shares of Common Stock, the holder of a Closing Warrant shall be entitled to receive
as the Alternative Issuance, the highest amount of cash, securities or other property to which such holder would actually have been entitled
as a stockholder if such Closing Warrant holder had exercised the Closing Warrant prior to the expiration of such tender or exchange offer,
accepted such offer and all of the Common Stock held by such holder had been purchased pursuant to such tender or exchange offer, subject
to adjustments (from and after the consummation of such tender or exchange offer) as nearly equivalent as possible to the adjustments
provided for in this Section 4; provided, further, that if less than 70% of the consideration receivable by the holders
of the Common Stock in the applicable event is payable in the form of common stock in the successor entity that is listed for trading
on a national securities exchange or is quoted in an established over-the-counter market, or is to be so listed for trading or quoted
immediately following such event, and if the Registered Holder properly exercises the Closing Warrant within thirty (30) days following
the public disclosure of the consummation of such applicable event by the Company pursuant to a Current Report on Form 8-K filed with
the Commission, the Warrant Price shall be reduced by an amount (in dollars) (but in no event less than zero) equal to the difference
of (i) the Warrant Price in effect prior to such reduction minus (ii) (A) the Per Share Consideration (as defined below) minus (B) the
Black-Scholes Warrant Value (as defined below). The “Black-Scholes Warrant Value” means the value of a Closing
Warrant immediately prior to the consummation of the applicable event based on the Black-Scholes Warrant Model for a Capped American Call
on Bloomberg Financial Markets (“Bloomberg”). For purposes of calculating such amount, (1) Section 6
of this Agreement shall be taken into account, (2) the price of each share of Common Stock shall be the volume weighted average price
of the Common Stock as reported during the ten (10) trading day period ending on the trading day prior to the effective date of the applicable
event, (3) the assumed volatility shall be the 90 day volatility obtained from the HVT function on Bloomberg determined as of the trading
day immediately prior to the day of the announcement of the applicable event, and (4) the assumed risk-free interest rate shall correspond
to the U.S. Treasury rate for a period equal to the remaining term of the Closing Warrant. “Per Share Consideration”
means (i) if the consideration paid to holders of the Common Stock consists exclusively of cash, the amount of such cash per share of
Common Stock, and (ii) in all other cases, the amount of cash per share of Common Stock, if any, paid to holders plus the volume weighted
average price of the Common Stock as reported during the ten (10) trading day period ending on the trading day prior to the effective
date of the applicable event. If any reclassification or reorganization also results in a change in shares of Common Stock covered by
subsection 4.1.1, then such adjustment shall be made pursuant to subsection 4.1.1 or Sections 4.2, 4.3 and
this Section 4.4. The provisions of this Section 4.4 shall similarly apply to successive reclassifications, reorganizations,
mergers or consolidations, sales or other transfers. In no event will the Warrant Price be reduced to less than the par value per share
issuable upon exercise of the Closing Warrant.

 

    Exhibit A-7

     

    

 

4.5 Notices of Changes in
Closing Warrant. Upon every adjustment of the Warrant Price or the number of shares of Common Stock issuable upon exercise of a Closing
Warrant, the Company shall give written notice thereof to the Warrant Agent, which notice shall state the Warrant Price resulting from
such adjustment and the increase or decrease, if any, in the number of shares of Common Stock purchasable at such price upon the exercise
of a Closing Warrant, setting forth in reasonable detail the method of calculation and the facts upon which such calculation is based.
Upon the occurrence of any event specified in Sections 4.1, 4.2, 4.3 or 4.4, the Company shall give written
notice of the occurrence of such event to each holder of a Closing Warrant, at the last address set forth for such holder in the Warrant
Register, of the record date or the effective date of the event. Failure to give such notice, or any defect therein, shall not affect
the legality or validity of such event.

 

4.6 No Fractional Shares.
Notwithstanding any provision contained in this Agreement to the contrary, the Company shall not issue fractional shares of Common Stock
upon the exercise of Closing Warrants. If, by reason of any adjustment made pursuant to this Section 4, the holder of any Closing
Warrant would be entitled, upon the exercise of such Closing Warrant, to receive a fractional interest in a share, the Company shall,
upon such exercise, round down to the nearest whole number the number of shares of Common Stock to be issued to such holder.

 

4.7 Form of Closing Warrant.
The form of Closing Warrant need not be changed because of any adjustment pursuant to this Section 4, and Closing Warrants issued
after such adjustment may state the same Warrant Price and the same number of shares of Common Stock as is stated in the Closing Warrants
initially issued pursuant to this Agreement; provided, however, that the Company may at any time in its sole discretion
make any change in the form of Closing Warrant that the Company may deem appropriate and that does not affect the substance thereof, and
any Closing Warrant thereafter issued or countersigned, whether in exchange or substitution for an outstanding Closing Warrant or otherwise,
may be in the form as so changed.

 

4.8 Other Events. In
case any event shall occur affecting the Company as to which none of the provisions of the preceding subsections of this Section 4
are strictly applicable, but which would require an adjustment to the terms of the Closing Warrants in order to (i) avoid an adverse impact
on the Closing Warrants and (ii) effectuate the intent and purpose of this Section 4, then, in each such case, the Company shall
appoint a firm of independent public accountants, investment banking or other appraisal firm of recognized national standing, which shall
give its opinion as to whether or not any adjustment to the rights represented by the Closing Warrants is necessary to effectuate the
intent and purpose of this Section 4 and, if they determine that an adjustment is necessary, the terms of such adjustment; provided,
however, that under no circumstances shall the Closing Warrants be adjusted pursuant to this Section 4.8 as a result of
any issuance of securities in connection with a Business Combination. The Company shall adjust the terms of the Closing Warrants in a
manner that is consistent with any adjustment recommended in such opinion.

 

4.9 No Adjustment. For
the avoidance of doubt, no adjustment shall be made to the terms of the Closing Warrants solely as a result of an adjustment to the conversion
ratio of the Class B Common Stock into shares of Common Stock or the conversion of the shares of Class B Common Stock into shares of Common
Stock, in each case, pursuant to the Company’s amended and restated certificate of incorporation, as may be amended from time to
time.

 

5. Transfer and Exchange
of Closing Warrants.

 

5.1 Registration of Transfer.
The Warrant Agent shall register the transfer, from time to time, of any outstanding Closing Warrant upon the Warrant Register, upon surrender
of such Closing Warrant for transfer, in the case of certificated Closing Warrants, properly endorsed with signatures properly guaranteed
and accompanied by appropriate instructions for transfer. Upon any such transfer, a new Closing Warrant representing an equal aggregate
number of Closing Warrants shall be issued and the old Closing Warrant shall be cancelled by the Warrant Agent. In the case of certificated
Closing Warrants, the Closing Warrants so cancelled shall be delivered by the Warrant Agent to the Company from time to time upon request.

 

    Exhibit A-8

     

    

 

5.2 Procedure for Surrender
of Closing Warrants. Closing Warrants may be surrendered to the Warrant Agent, together with a written request for exchange or transfer,
and thereupon the Warrant Agent shall issue in exchange therefor one or more new Closing Warrants as requested by the Registered Holder
of the Closing Warrants so surrendered, representing an equal aggregate number of Closing Warrants; provided, however, that
except as otherwise provided herein or in any Book-Entry Warrant Certificate, each Book-Entry Warrant Certificate may be transferred only
in whole and only to the Depositary, to another nominee of the Depositary, to a successor depository, or to a nominee of a successor depository;
provided further, however, that in the event that a Closing Warrant surrendered for transfer bears a restrictive legend,
the Warrant Agent shall not cancel such Closing Warrant and issue new Closing Warrants in exchange thereof until the Warrant Agent has
received an opinion of counsel for the Company stating that such transfer may be made and indicating whether the new Closing Warrants
must also bear a restrictive legend.

 

5.3 Fractional Closing Warrants.
The Warrant Agent shall not be required to effect any registration of transfer or exchange which shall result in the issuance of a warrant
certificate or book-entry position for a fraction of a warrant.

 

5.4 Service Charges.
No service charge shall be made for any exchange or registration of transfer of Closing Warrants.

 

5.5 Warrant Execution and
Countersignature. The Warrant Agent is hereby authorized to countersign and to deliver, in accordance with the terms of this Agreement,
the Closing Warrants required to be issued pursuant to the provisions of this Section 5, and the Company, whenever required by
the Warrant Agent, shall supply the Warrant Agent with Closing Warrants duly executed on behalf of the Company for such purpose.

 

6. Redemption.

 

6.1 Redemption of Closing
Warrants for Cash at $0.01 Per Closing Warrant. Subject to Section 6.5 hereof, at any time during the Exercise Period, the
Company may, at its option, redeem all (and not part) of the outstanding Closing Warrants at the office of the Warrant Agent, upon notice
to the Registered Holders of the Closing Warrants, as described in Section 6.3 below, at a Redemption Price (as defined in Section
6.3 hereof) of $0.01 per Closing Warrant, provided that (a) the last reported sale price of the Common Stock for any 20 trading
days within a 30-trading day period ending on the third trading day prior to the date on which the Company sends the notice of redemption
to the Registered Holders equals or exceeds $18.00 per share (subject to adjustment in compliance with Section 4 hereof) and (b)
there is an effective registration statement covering the shares of Common Stock issuable upon exercise of the Closing Warrants, and a
current prospectus relating thereto, available throughout the 30-day Redemption Period (as defined in Section 6.3 below).

 

6.2 Redemption of Closing
Warrants for Cash at $0.10 Per Closing Warrant. Subject to Section 6.5 hereof, at any time during the Exercise Period, the
Company may, at its option, redeem all (and not part) of the outstanding Closing Warrants at the office of the Warrant Agent, upon notice
to the Registered Holders of the Closing Warrants, as described in Section 6.3 below, at a Redemption Price of $0.10 per Closing
Warrant, provided that the last reported sale price of the Common Stock for any 20 trading days within a 30-trading day period
ending on the third trading day prior to the date on which the Company sends the notice of redemption to the Registered Holder equals
or exceeds $10.00 per share (subject to adjustment in compliance with Section 4 hereof). During the 30-day Redemption Period in
connection with a redemption pursuant to this Section 6.2, Registered Holders of the Closing Warrants may elect to exercise their
Closing Warrants; provided, that any such exercise be on a “cashless basis” and receive a number of shares of Common
Stock determined by reference to the table below, based on the Redemption Date (calculated for purposes of the table as the period to
expiration of the Closing Warrants) and the “Redemption Fair Market Value” (as such term is defined in this Section 6.2)
(a “Make-Whole Exercise”). Solely for purposes of this Section 6.2, the “Redemption Fair
Market Value” shall mean the volume-weighted average price of the Common Stock as reported during the ten (10) trading days
immediately following the date on which notice of redemption pursuant to this Section 6.2 is sent to the Registered Holders. In
connection with any redemption pursuant to this Section 6.2, the Company shall provide the Registered Holders with the Redemption
Fair Market Value no later than one (1) Business Day after the ten (10) trading day period described above ends.

 

    Exhibit A-9

     

    

 

	Redemption Date	 	Redemption Date Fair Market Value of Common Stock	 
	(period to expiration of warrants)	 	<10.00	 	 	11.00	 	 	12.00	 	 	13.00	 	 	14.00	 	 	15.00	 	 	16.00	 	 	17.00	 	 	>18.00	 
	60 months	 	 	0.261	 	 	 	0.281	 	 	 	0.297	 	 	 	0.311	 	 	 	0.324	 	 	 	0.337	 	 	 	0.348	 	 	 	0.358	 	 	 	0.361	 
	57 months	 	 	0.257	 	 	 	0.277	 	 	 	0.294	 	 	 	0.310	 	 	 	0.324	 	 	 	0.337	 	 	 	0.348	 	 	 	0.358	 	 	 	0.361	 
	54 months	 	 	0.252	 	 	 	0.272	 	 	 	0.291	 	 	 	0.307	 	 	 	0.322	 	 	 	0.335	 	 	 	0.347	 	 	 	0.357	 	 	 	0.361	 
	51 months	 	 	0.246	 	 	 	0.268	 	 	 	0.287	 	 	 	0.304	 	 	 	0.320	 	 	 	0.333	 	 	 	0.346	 	 	 	0.357	 	 	 	0.361	 
	48 months	 	 	0.241	 	 	 	0.263	 	 	 	0.283	 	 	 	0.301	 	 	 	0.317	 	 	 	0.332	 	 	 	0.344	 	 	 	0.356	 	 	 	0.361	 
	45 months	 	 	0.235	 	 	 	0.258	 	 	 	0.279	 	 	 	0.298	 	 	 	0.315	 	 	 	0.330	 	 	 	0.343	 	 	 	0.356	 	 	 	0.361	 
	42 months	 	 	0.228	 	 	 	0.252	 	 	 	0.274	 	 	 	0.294	 	 	 	0.312	 	 	 	0.328	 	 	 	0.342	 	 	 	0.355	 	 	 	0.361	 
	39 months	 	 	0.221	 	 	 	0.246	 	 	 	0.269	 	 	 	0.290	 	 	 	0.309	 	 	 	0.325	 	 	 	0.340	 	 	 	0.354	 	 	 	0.361	 
	36 months	 	 	0.213	 	 	 	0.239	 	 	 	0.263	 	 	 	0.285	 	 	 	0.305	 	 	 	0.323	 	 	 	0.339	 	 	 	0.353	 	 	 	0.361	 
	33 months	 	 	0.205	 	 	 	0.232	 	 	 	0.257	 	 	 	0.280	 	 	 	0.301	 	 	 	0.320	 	 	 	0.337	 	 	 	0.352	 	 	 	0.361	 
	30 months	 	 	0.196	 	 	 	0.224	 	 	 	0.250	 	 	 	0.274	 	 	 	0.297	 	 	 	0.316	 	 	 	0.335	 	 	 	0.351	 	 	 	0.361	 
	27 months	 	 	0.185	 	 	 	0.214	 	 	 	0.242	 	 	 	0.268	 	 	 	0.291	 	 	 	0.313	 	 	 	0.332	 	 	 	0.350	 	 	 	0.361	 
	24 months	 	 	0.173	 	 	 	0.204	 	 	 	0.233	 	 	 	0.260	 	 	 	0.285	 	 	 	0.308	 	 	 	0.329	 	 	 	0.348	 	 	 	0.361	 
	21 months	 	 	0.161	 	 	 	0.193	 	 	 	0.223	 	 	 	0.252	 	 	 	0.279	 	 	 	0.304	 	 	 	0.326	 	 	 	0.347	 	 	 	0.361	 
	18 months	 	 	0.146	 	 	 	0.179	 	 	 	0.211	 	 	 	0.242	 	 	 	0.271	 	 	 	0.298	 	 	 	0.322	 	 	 	0.345	 	 	 	0.361	 
	15 months	 	 	0.130	 	 	 	0.164	 	 	 	0.197	 	 	 	0.230	 	 	 	0.262	 	 	 	0.291	 	 	 	0.317	 	 	 	0.342	 	 	 	0.361	 
	12 months	 	 	0.111	 	 	 	0.146	 	 	 	0.181	 	 	 	0.216	 	 	 	0.250	 	 	 	0.282	 	 	 	0.312	 	 	 	0.339	 	 	 	0.361	 
	9 months	 	 	0.090	 	 	 	0.125	 	 	 	0.162	 	 	 	0.199	 	 	 	0.237	 	 	 	0.272	 	 	 	0.305	 	 	 	0.336	 	 	 	0.361	 
	6 months	 	 	0.065	 	 	 	0.099	 	 	 	0.137	 	 	 	0.178	 	 	 	0.219	 	 	 	0.259	 	 	 	0.296	 	 	 	0.331	 	 	 	0.361	 
	3 months	 	 	0.034	 	 	 	0.065	 	 	 	0.104	 	 	 	0.150	 	 	 	0.197	 	 	 	0.243	 	 	 	0.286	 	 	 	0.326	 	 	 	0.361	 
	0 months	 	 	—	 	 	 	—	 	 	 	0.042	 	 	 	0.115	 	 	 	0.179	 	 	 	0.233	 	 	 	0.281	 	 	 	0.323	 	 	 	0.361	 

 

The exact Redemption Fair
Market Value and Redemption Date (as defined below) may not be set forth in the table above, in which case, if the Redemption Fair Market
Value is between two values in the table or the Redemption Date is between two redemption dates in the table, the number of shares of
Common Stock to be issued for each Closing Warrant exercised in a Make-Whole Exercise will be determined by a straight-line interpolation
between the number of shares set forth for the higher and lower Redemption Fair Market Values and the earlier and later redemption dates,
as applicable, based on a 365- or 366-day year, as applicable.

 

The share prices set forth
in the column headings of the table above shall be adjusted as of any date on which the number of shares of Common Stock issuable upon
exercise of a Closing Warrant or the Warrant Price is adjusted pursuant to Section 4 hereof. If the number of shares of Common
Stock issuable upon exercise of a Closing Warrant is adjusted pursuant to Section 4 hereof, the adjusted share prices in the column
headings shall equal the share prices immediately prior to such adjustment, multiplied by a fraction, the numerator of which is the Warrant
Price after such adjustment and the denominator of which is the Warrant Price immediately prior to such adjustment. In such an event,
the number of shares in the table above shall be adjusted by multiplying such share amounts by a fraction, the numerator of which is the
number of shares deliverable upon exercise of a Closing Warrant immediately prior to such adjustment and the denominator of which is the
number of shares deliverable upon exercise of a Closing Warrant as so adjusted. If the Warrant Price is adjusted, (a) in the case of an
adjustment pursuant to Section 4.3.2 hereof, the adjusted share prices in the column headings shall equal the share prices immediately
prior to such adjustment multiplied by a fraction, the numerator of which is the higher of the Market Value and the Newly Issued Price
and the denominator of which is $10.00 and (b) in the case of an adjustment pursuant to Section 4.1.2 hereof, the adjusted share
prices in the column headings shall equal the share prices immediately prior to such adjustment less the decrease in the Warrant Price
pursuant to such Warrant Price adjustment. In no event shall the number of shares issued in connection with a Make-Whole Exercise exceed
0.361 shares of Common Stock per Closing Warrant (subject to adjustment).

 

6.3 Date Fixed for, and Notice
of, Redemption. In the event that the Company elects to redeem all of the Closing Warrants, pursuant to Sections 6.1 or 6.2,
the Company shall fix a date for the redemption (the “Redemption Date”). Notice of redemption shall be mailed
by first class mail, postage prepaid, by the Company not less than thirty (30) days prior to the Redemption Date (the “30-day
Redemption Period”) to the Registered Holders of the Closing Warrants to be redeemed at their last addresses as they shall
appear on the registration books. Any notice mailed in the manner herein provided shall be conclusively presumed to have been duly given
whether or not the Registered Holder received such notice. As used in this Agreement, “Redemption Price” shall
mean the price per Closing Warrant at which any Closing Warrants are redeemed pursuant to Section 6.1 or Section 6.2 hereof.

 

6.4 Exercise After Notice
of Redemption. The Closing Warrants may be exercised, for cash at any time after notice of redemption pursuant to Section 6.1
hereof shall have been given by the Company pursuant to Section 6.3 hereof and prior to the Redemption Date. The Closing Warrants
may be exercised only on a “cashless basis” in accordance with Section 6.2 hereof at any time after notice of redemption
pursuant to Section 6.2 hereof shall have been given by the Company pursuant to Section 6.3 hereof and prior to the Redemption
Date. On and after the Redemption Date, the record holder of the Closing Warrants shall have no further rights except to receive, upon
surrender of the Closing Warrants, the Redemption Price.

 

    Exhibit A-10

     

    

 

6.5 Exclusion of Closing
Warrants. The Company agrees that the redemption rights provided in Section 6.1 hereof shall not apply to the Closing Warrants if
at the time of the redemption such Closing Warrants continue to be held by the original purchasers thereof or their Permitted Transferees.
However, once such Closing Warrants are transferred (other than to Permitted Transferees in accordance with Section 3.3.1 hereof), the
Company may redeem the Closing Warrants pursuant to Section 6.1 hereof, provided that the criteria for redemption are met, including the
opportunity of the holder of such Closing Warrants to exercise such Closing Warrants prior to redemption pursuant to Section 6.4 hereof.
Closing Warrants that are transferred to persons other than Permitted Transferees shall upon such transfer cease to be Closing Warrants
and shall become Public Warrants under the Public Warrant Agreement.

 

7. Other Provisions Relating
to Rights of Holders of Closing Warrants.

 

7.1 No Rights as Stockholder.
A Closing Warrant does not entitle the Registered Holder thereof to any of the rights of a stockholder of the Company, including, without
limitation, the right to receive dividends, or other distributions, exercise any preemptive rights to vote or to consent or to receive
notice as a stockholder in respect of the meetings of stockholders or the election of directors of the Company or any other matter.

 

7.2 Lost, Stolen, Mutilated,
or Destroyed Closing Warrants. If any Closing Warrant is lost, stolen, mutilated, or destroyed, the Company and the Warrant Agent
may on such terms as to indemnity or otherwise as they may in their discretion impose (which shall, in the case of a mutilated Closing
Warrant, include the surrender thereof), issue a new Closing Warrant of like denomination, tenor, and date as the Closing Warrant so lost,
stolen, mutilated, or destroyed. Any such new Closing Warrant shall constitute a substitute contractual obligation of the Company, whether
or not the allegedly lost, stolen, mutilated, or destroyed Closing Warrant shall be at any time enforceable by anyone.

 

7.3 Reservation of Common
Stock. The Company shall at all times reserve and keep available a number of its authorized but unissued shares of Common Stock that
shall be sufficient to permit the exercise in full of all outstanding Closing Warrants issued pursuant to this Agreement.

 

7.4 Registration of Common
Stock; Cashless Exercise at Company’s Option.

 

7.4.1 Registration of the
Common Stock. The Company agrees that as soon as practicable, but in no event later than fifteen (15) Business Days after the closing
of its initial Business Combination, it shall use its commercially reasonable efforts to file with the Commission a registration statement
for the registration, under the Securities Act, of the shares of Common Stock issuable upon exercise of the Closing Warrants. The Company
shall use its commercially reasonable efforts to cause the same to become effective within 60 Business Days after the closing of the Company’s
initial Business Combination and to maintain the effectiveness of such registration statement, and a current prospectus relating thereto,
until the expiration or redemption of the Closing Warrants in accordance with the provisions of this Agreement. If any such registration
statement has not been declared effective by the 60th Business Day following the closing of the Company’s initial Business Combination,
holders of the Closing Warrants shall have the right, during the period beginning on the 61st Business Day after the closing of the Business
Combination and ending upon such registration statement being declared effective by the Commission, and during any other period when the
Company shall fail to have maintained an effective registration statement covering the shares of Common Stock issuable upon exercise of
the Closing Warrants, to exercise such Closing Warrants on a “cashless basis,” by exchanging the Closing Warrants (in accordance
with Section 3(a)(9) of the Securities Act (or any successor rule) or another exemption) for that number of shares of Common Stock equal
to the lesser of (A) the quotient obtained by dividing (x) the product of the number of shares of Common Stock underlying the Closing
Warrants, multiplied by the excess of the “Fair Market Value” (as defined below) over the Warrant Price by (y) the Fair Market
Value and (B) 0.361 per whole Closing Warrant. Solely for purposes of this subsection 7.4.1, “Fair Market Value” shall
mean the average of the last reported last sale prices of the Common Stock as reported during the ten (10) trading day period ending on
the third trading day prior to the date that notice of exercise is received by the Warrant Agent from the holder of such Closing Warrants
or his, her or its securities broker or intermediary. The date that notice of cashless exercise is received by the Warrant Agent shall
be conclusively determined by the Warrant Agent. In connection with the “cashless exercise” of a Closing Warrant, the Company
shall, upon request, provide the Warrant Agent with an opinion of counsel for the Company (which shall be an outside law firm with securities
law experience) stating that (i) the exercise of the Closing Warrants on a cashless basis in accordance with this subsection 7.4.1
is not required to be registered under the Securities Act and (ii) the shares of Common Stock issued upon such exercise shall be freely
tradable under United States federal securities laws by anyone who is not an affiliate (as such term is defined in Rule 144 under the
Securities Act (or any successor rule)) of the Company and, accordingly, shall not be required to bear a restrictive legend. Except as
provided in subsection 7.4.2, for the avoidance of any doubt, unless and until all of the Closing Warrants have been exercised
or have expired, the Company shall continue to be obligated to comply with its registration obligations under the first three sentences
of this subsection 7.4.1.

 

    Exhibit A-11

     

    

 

7.4.2 Cashless Exercise
at Company’s Option. If the Common Stock is at the time of any exercise of a Closing Warrant not listed on a national securities
exchange such that, as a result, the Common Stock does not satisfy the definition of a “covered security” under Section 18(b)(1)
of the Securities Act (or any successor statute), the Company may, at its option, (i) require holders of Closing Warrants who exercise
Closing Warrants to exercise such Closing Warrants on a “cashless basis” in accordance with Section 3(a)(9) of the Securities
Act (or any successor statute) as described in subsection 7.4.1 and (ii) in the event the Company so elects, the Company shall
not be required to file or maintain in effect a registration statement for the registration, under the Securities Act, of the shares of
Common Stock issuable upon exercise of the Closing Warrants, notwithstanding anything in this Agreement to the contrary, and (y) use its
commercially reasonable efforts to register or qualify for sale the shares of Common Stock issuable upon exercise of the Closing Warrant
under applicable blue sky laws to the extent an exemption is not available.

 

8. Concerning the Closing Warrant Agent and
Other Matters.

 

8.1 Payment of Taxes.
The Company shall from time to time promptly pay all taxes and charges that may be imposed upon the Company or the Warrant Agent in respect
of the issuance or delivery of shares of Common Stock upon the exercise of the Closing Warrants, but the Company shall not be obligated
to pay any transfer taxes in respect of the Closing Warrants or such shares of Common Stock.

 

8.2 Resignation, Consolidation,
or Merger of Warrant Agent.

 

8.2.1 Appointment of Successor
Warrant Agent. The Warrant Agent, or any successor to it hereafter appointed, may resign its duties and be discharged from all further
duties and liabilities hereunder after giving sixty (60) days’ notice in writing to the Company. If the office of the Warrant Agent
becomes vacant by resignation or incapacity to act or otherwise, the Company shall appoint in writing a successor Warrant Agent in place
of the Warrant Agent. If the Company shall fail to make such appointment within a period of thirty (30) days after it has been notified
in writing of such resignation or incapacity by the Warrant Agent or by the holder of a Closing Warrant (who shall, with such notice,
submit his, her or its Closing Warrant for inspection by the Company), then the holder of any Closing Warrant may apply to the Supreme
Court of the State of New York for the County of New York for the appointment of a successor Warrant Agent at the Company’s cost.
Any successor Warrant Agent, whether appointed by the Company or by such court, shall be a corporation or other entity organized and existing
under the laws of the State of New York, in good standing and having its principal office in the United States of America, and authorized
under such laws to exercise corporate trust powers and subject to supervision or examination by federal or state authority. After appointment,
any successor Warrant Agent shall be vested with all the authority, powers, rights, immunities, duties, and obligations of its predecessor
Warrant Agent with like effect as if originally named as Warrant Agent hereunder, without any further act or deed; but if for any reason
it becomes necessary or appropriate, the predecessor Warrant Agent shall execute and deliver, at the expense of the Company, an instrument
transferring to such successor Warrant Agent all the authority, powers, and rights of such predecessor Warrant Agent hereunder; and upon
request of any successor Warrant Agent the Company shall make, execute, acknowledge, and deliver any and all instruments in writing for
more fully and effectually vesting in and confirming to such successor Warrant Agent all such authority, powers, rights, immunities, duties,
and obligations.

 

8.2.2 Notice of Successor
Warrant Agent. In the event a successor Warrant Agent shall be appointed, the Company shall give notice thereof to the predecessor
Warrant Agent and the Transfer Agent for the Common Stock not later than the effective date of any such appointment.

 

8.2.3 Merger or Consolidation
of Warrant Agent. Any entity into which the Warrant Agent may be merged or with which it may be consolidated or any entity resulting
from any merger or consolidation to which the Warrant Agent shall be a party shall be the successor Warrant Agent under this Agreement
without any further act.

 

8.3 Fees and Expenses of
Warrant Agent.

 

8.3.1 Remuneration.
The Company agrees to pay the Warrant Agent reasonable remuneration for its services as such Warrant Agent hereunder and shall, pursuant
to its obligations under this Agreement, reimburse the Warrant Agent upon demand for all expenditures that the Warrant Agent may reasonably
incur in the execution of its duties hereunder.

 

    Exhibit A-12

     

    

 

8.3.2 Further Assurances.
The Company agrees to perform, execute, acknowledge, and deliver or cause to be performed, executed, acknowledged, and delivered all such
further and other acts, instruments, and assurances as may reasonably be required by the Warrant Agent for the carrying out or performing
of the provisions of this Agreement.

 

8.4 Liability of Warrant
Agent.

 

8.4.1 Reliance on Company
Statement. Whenever in the performance of its duties under this Agreement, the Warrant Agent shall deem it necessary or desirable
that any fact or matter be proved or established by the Company prior to taking or suffering any action hereunder, such fact or matter
(unless other evidence in respect thereof be herein specifically prescribed) may be deemed to be conclusively proved and established by
a statement signed by the Chief Executive Officer, Chief Financial Officer, President, Secretary or Chairman of the Board of the Company
and delivered to the Warrant Agent. The Warrant Agent may rely upon such statement for any action taken or suffered in good faith by it
pursuant to the provisions of this Agreement.

 

8.4.2 Indemnity. The
Warrant Agent shall be liable hereunder only for its own gross negligence, willful misconduct, fraud or bad faith. The Company agrees
to indemnify the Warrant Agent and save it harmless against any and all liabilities, including judgments, out-of-pocket costs and reasonable
outside counsel fees, for anything done or omitted by the Warrant Agent in the execution of this Agreement, except as a result of the
Warrant Agent’s gross negligence, willful misconduct, fraud or bad faith.

 

8.4.3 Exclusions. The
Warrant Agent shall have no responsibility with respect to the validity of this Agreement or with respect to the validity or execution
of any Closing Warrant (except its countersignature thereof). The Warrant Agent shall not be responsible for any breach by the Company
of any covenant or condition contained in this Agreement or in any Closing Warrant. The Warrant Agent shall not be responsible to make
any adjustments required under the provisions of Section 4 hereof or responsible for the manner, method, or amount of any such
adjustment or the ascertaining of the existence of facts that would require any such adjustment; nor shall it by any act hereunder be
deemed to make any representation or warranty as to the authorization or reservation of any shares of Common Stock to be issued pursuant
to this Agreement or any Closing Warrant or as to whether any shares of Common Stock shall, when issued, be valid and fully paid and non-assessable.

 

8.5 Acceptance of Agency.
The Warrant Agent hereby accepts the agency established by this Agreement and agrees to perform the same upon the terms and conditions
herein set forth and among other things, shall account promptly to the Company with respect to Closing Warrants exercised and concurrently
account for, and pay to the Company, all monies received by the Warrant Agent for the purchase of shares of Common Stock through the exercise
of the Closing Warrants.

 

8.6 Waiver. The Warrant
Agent has no right of set-off or any other right, title, interest or claim of any kind (“Claim”) in, or to any
distribution of, the Trust Account (as defined in that certain Investment Management Trust Agreement, dated as of the date hereof, by
and between the Company and the Warrant Agent as trustee thereunder) and hereby agrees not to seek recourse, reimbursement, payment or
satisfaction for any Claim against the Trust Account for any reason whatsoever. The Warrant Agent hereby waives any and all Claims against
the Trust Account and any and all rights to seek access to the Trust Account.

 

9. Miscellaneous Provisions.

 

9.1 Successors. All the
covenants and provisions of this Agreement by or for the benefit of the Company or the Warrant Agent shall bind and inure to the benefit
of their respective successors and assigns.

 

9.2 Notices. Any notice,
statement or demand authorized by this Agreement to be given or made by the Warrant Agent or by the holder of any Closing Warrant to or
on the Company shall be sufficiently given when so delivered if by hand or overnight delivery or if sent by certified mail or private
courier service within five (5) days after deposit of such notice, postage prepaid, addressed (until another address is filed in writing
by the Company with the Warrant Agent), as follows:

 

Voltus Technologies, Inc.

2443 Fillmore Street, #308-3427

San Francisco, California 94115

Attn: Gregg Dixon

Laurie Harrison

Email: greggdixon@voltus.co

lharrison@voltus.co

 

    Exhibit A-13

     

    

 

Any notice, statement or demand authorized by this Agreement to be
given or made by the holder of any Closing Warrant or by the Company to or on the Warrant Agent shall be sufficiently given when so delivered
if by hand or overnight delivery or if sent by certified mail or private courier service within five (5) days after deposit of such notice,
postage prepaid, addressed (until another address is filed in writing by the Warrant Agent with the Company), as follows:

 

Continental Stock Transfer &
Trust Company

1 State Street, 30th Floor

New York, NY 10004

Attn: Compliance Department

 

With a copy in each case to:

Morgan Stanley & Co. LLC

1585 Broadway

New York, NY 10036

 

and

 

Moelis & Company LLC

399 Park Avenue

5th Floor

New York, NY 10022

 

and

 

Nomura Securities International,
Inc.

Worldwide Plaza

309 West 49th Street

New York, NY 10019-7316

 

and

 

Kirkland & Ellis LLP

609 Main Street, Suite 4700

Houston, Texas 77002

Attn: Cephas Sekhar, Esq.

Matthew Turner, Esq.

Email: cephas.sekhar@kirkland.com

matthew.turner@kirkland.com

 

9.3 Applicable Law. The
validity, interpretation, and performance of this Agreement and of the Closing Warrants shall be governed in all respects by the laws
of the State of New York, without giving effect to conflicts of law principles that would result in the application of the substantive
laws of another jurisdiction. The Company hereby agrees that any action, proceeding or claim against it arising out of or relating in
any way to this Agreement shall be brought and enforced in the courts of the State of New York or the United States District Court for
the Southern District of New York, and irrevocably submits to such jurisdiction. The Company hereby waives any objection to such jurisdiction
and that such courts represent an inconvenient forum.

 

9.4 Persons Having Rights
under this Agreement. Nothing in this Agreement shall be construed to confer upon, or give to, any person, corporation or other entity
other than the parties hereto and the Registered Holders of the Closing Warrants any right, remedy, or claim under or by reason of this
Agreement or of any covenant, condition, stipulation, promise, or agreement hereof. All covenants, conditions, stipulations, promises,
and agreements contained in this Agreement shall be for the sole and exclusive benefit of the parties hereto and their successors and
assigns and of the Registered Holders of the Closing Warrants.

 

9.5 Examination of the Closing
Warrant Agreement. A copy of this Agreement shall be available at all reasonable times at the office of the Warrant Agent in the Borough
of Manhattan, City and State of New York, for inspection by the Registered Holder of any Closing Warrant. The Warrant Agent may require
any such holder to submit such holder’s Closing Warrant for inspection by the Warrant Agent.

 

9.6 Counterparts. This
Agreement may be executed in any number of original or facsimile counterparts and each of such counterparts shall for all purposes be
deemed to be an original, and all such counterparts shall together constitute but one and the same instrument. A signed copy of this Agreement
delivered by facsimile, e-mail or other means of electronic transmission shall be deemed to have the same legal effect as delivery of
an original signed copy of this Agreement.

 

    Exhibit A-14

     

    

 

9.7 Effect of Headings.
The section headings herein are for convenience only and are not part of this Agreement and shall not affect the interpretation thereof.

 

9.8 Amendments. This
Agreement may be amended by the parties hereto without the consent of any Registered Holder (i) for the purpose of curing any ambiguity
or to correct any mistake, or curing, correcting or supplementing any defective provision contained herein or adding or changing any other
provisions with respect to matters or questions arising under this Agreement as the parties may deem necessary or desirable and that the
parties deem shall not adversely affect the interest of the Registered Holders, and (ii) to provide for the delivery of Alternative Issuance
pursuant to Section 4.4. All other modifications or amendments, including any amendment to increase the Warrant Price or shorten
the Exercise Period, shall require the vote or written consent of the Registered Holders of at least 65% of the then outstanding Closing
Warrants. Notwithstanding the foregoing, the Company may lower the Warrant Price or extend the duration of the Exercise Period pursuant
to Sections 3.1 and 3.2, respectively, without the consent of the Registered Holders.

 

9.9 Severability. This
Agreement shall be deemed severable, and the invalidity or unenforceability of any term or provision hereof shall not affect the validity
or enforceability of this Agreement or of any other term or provision hereof. Furthermore, in lieu of any such invalid or unenforceable
term or provision, the parties hereto intend that there shall be added as a part of this Agreement a provision as similar in terms to
such invalid or unenforceable provision as may be possible and be valid and enforceable.

 

Exhibit A – Form of Closing Warrant Certificate.

 

[Signature Page Follows]

 

    Exhibit A-15

     

    

 

IN WITNESS WHEREOF, the parties
hereto have caused this Agreement to be duly executed as of the date first above written.

 

	 	VOLTUS TECHNOLOGIES, INC.
	 	 	 
	 	By:	                    
	 	Name:	 
	 	Title:	 
	 	 	 
	 	CONTINENTAL STOCK TRANSFER &TRUST COMPANY, as Warrant Agent
	 	 	 
	 	By:	 
	 	Name:	 
	 	Title:	 

 

[Signature Page to Closing Warrant Agreement]

 

    Exhibit A-16

     

    

 

EXHIBIT A

 

[Form of Closing Warrant Certificate]

 

[FACE]

 

Number

 

CLOSING WARRANTS

THIS CLOSING WARRANT SHALL BE VOID IF NOT EXERCISED
PRIOR TO

THE EXPIRATION OF THE EXERCISE PERIOD PROVIDED
FOR

IN THE CLOSING WARRANT AGREEMENT DESCRIBED BELOW

VOLTUS TECHNOLOGIES, INC.

Incorporated Under the Laws of the State of
Delaware

 

CUSIP [●]

 

Closing Warrant Certificate

 

This Closing Warrant Certificate certifies
that __________, or its registered assigns, is the registered holder of __________ warrant(s) evidenced hereby (the “Closing
Warrants” and each, a “Closing Warrant”) to purchase shares of Class A common stock, $0.0001 par
value per share (“Common Stock”), of Voltus Technologies, Inc., a Delaware corporation (the “Company”).
Each Closing Warrant entitles the holder, upon exercise during the period set forth in the Closing Warrant Agreement referred to below,
to receive from the Company that number of fully paid and non-assessable shares of Common Stock as set forth below, at the exercise price
(the “Exercise Price”) as determined pursuant to the Closing Warrant Agreement, payable in lawful money (or
through “cashless exercise” as provided for in the Closing Warrant Agreement) of the United States of America
upon surrender of this Closing Warrant Certificate and payment of the Exercise Price at the office or agency of the Warrant Agent referred
to below, subject to the conditions set forth herein and in the Closing Warrant Agreement. Defined terms used in this Closing Warrant
Certificate but not defined herein shall have the meanings given to them in the Closing Warrant Agreement.

 

Each whole Closing Warrant is initially exercisable
for one fully paid and non-assessable share of Common Stock. No fractional shares will be issued upon exercise of any Closing Warrant.
If, upon the exercise of Closing Warrants, a holder would be entitled to receive a fractional interest in a share of Common Stock, the
Company will, upon exercise, round down to the nearest whole number the number of shares of Common Stock to be issued to the Closing Warrant
holder. The number of shares of Common Stock issuable upon exercise of the Closing Warrants is subject to adjustment upon the occurrence
of certain events set forth in the Closing Warrant Agreement.

 

The initial Exercise Price per share of Common
Stock for any Closing Warrant is equal to $11.50 per share. The Exercise Price is subject to adjustment upon the occurrence of certain
events set forth in the Closing Warrant Agreement.

 

Subject to the conditions set forth in the Closing
Warrant Agreement, the Closing Warrants may be exercised only during the Exercise Period and to the extent not exercised by the end of
such Exercise Period, such Closing Warrants shall become void.

 

Reference is hereby made to the further provisions
of this Closing Warrant Certificate set forth on the reverse hereof and such further provisions shall for all purposes have the same effect
as though fully set forth at this place.

 

This Closing Warrant Certificate shall not be valid
unless countersigned by the Warrant Agent, as such term is used in the Closing Warrant Agreement.

 

This Closing Warrant Certificate shall be governed
by and construed in accordance with the internal laws of the State of New York, without regard to conflicts of laws principles thereof.

 

	 	VOLTUS TECHNOLOGIES, INC.
	 	 	 
	 	By:	           
	 	Name:	 
	 	Title:	 
	 	 	 
	 	CONTINENTAL STOCK TRANSFER &

TRUST COMPANY, as Warrant Agent
	 	 	 
	 	By:	 
	 	Name:	 
	 	Title:	 

 

    A-1

     

    

 

[Form of Closing Warrant Certificate]

 

[Reverse]

 

The Closing Warrants evidenced by this Closing
Warrant Certificate are part of a duly authorized issue of Closing Warrants entitling the holder on exercise to receive shares of Common
Stock and are issued or to be issued pursuant to a Closing Warrant Agreement dated as of __________, 2021 (the “Closing Warrant
Agreement”), duly executed and delivered by the Company to Continental Stock Transfer & Trust Company, a New York corporation,
as warrant agent (the “Warrant Agent”), which Closing Warrant Agreement is hereby incorporated by reference
in and made a part of this instrument and is hereby referred to for a description of the rights, limitation of rights, obligations, duties
and immunities thereunder of the Warrant Agent, the Company and the holders (the words “holders” or “holder”
meaning the Registered Holders or Registered Holder, respectively) of the Closing Warrants. A copy of the Closing Warrant Agreement may
be obtained by the holder hereof upon written request to the Company. Defined terms used in this Closing Warrant Certificate but not defined
herein shall have the meanings given to them in the Closing Warrant Agreement.

 

Closing Warrants may be exercised at any time during
the Exercise Period set forth in the Closing Warrant Agreement. The holder of Closing Warrants evidenced by this Closing Warrant Certificate
may exercise them by surrendering this Closing Warrant Certificate, with the form of election to purchase set forth hereon properly completed
and executed, together with payment of the Exercise Price as specified in the Closing Warrant Agreement (or through “cashless exercise”
as provided for in the Closing Warrant Agreement) at the principal corporate trust office of the Warrant Agent. In the event that upon
any exercise of Closing Warrants evidenced hereby the number of Closing Warrants exercised shall be less than the total number of Closing
Warrants evidenced hereby, there shall be issued to the holder hereof or his, her or its assignee, a new Closing Warrant Certificate evidencing
the number of Closing Warrants not exercised.

 

Notwithstanding anything else in this Closing Warrant
Certificate or the Closing Warrant Agreement, no Closing Warrant may be exercised unless at the time of exercise (i) a registration statement
covering the shares of Common Stock to be issued upon exercise is effective under the Securities Act and (ii) a prospectus thereunder
relating to the shares of Common Stock is current, except through “cashless exercise” as provided for in the Closing Warrant
Agreement.

 

The Closing Warrant Agreement provides that upon
the occurrence of certain events the number of shares of Common Stock issuable upon exercise of the Closing Warrants set forth on the
face hereof may, subject to certain conditions, be adjusted. If, upon exercise of a Closing Warrant, the holder thereof would be entitled
to receive a fractional interest in a share of Common Stock, the Company shall, upon exercise, round down to the nearest whole number
of shares of Common Stock to be issued to the holder of the Closing Warrant.

 

Closing Warrant Certificates, when surrendered
at the principal corporate trust office of the Warrant Agent by the Registered Holder thereof in person or by legal representative or
attorney duly authorized in writing, may be exchanged, in the manner and subject to the limitations provided in the Closing Warrant Agreement,
but without payment of any service charge, for another Closing Warrant Certificate or Closing Warrant Certificates of like tenor evidencing
in the aggregate a like number of Closing Warrants.

 

Upon due presentation for registration of transfer
of this Closing Warrant Certificate at the office of the Warrant Agent a new Closing Warrant Certificate or Closing Warrant Certificates
of like tenor and evidencing in the aggregate a like number of Closing Warrants shall be issued to the transferee(s) in exchange for this
Closing Warrant Certificate, subject to the limitations provided in the Closing Warrant Agreement, without charge except for any tax or
other governmental charge imposed in connection therewith.

 

The Company and the Warrant Agent may deem and
treat the Registered Holder(s) hereof as the absolute owner(s) of this Closing Warrant Certificate (notwithstanding any notation of ownership
or other writing hereon made by anyone), for the purpose of any exercise hereof, of any distribution to the holder(s) hereof, and for
all other purposes, and neither the Company nor the Warrant Agent shall be affected by any notice to the contrary. Neither the Closing
Warrants nor this Closing Warrant Certificate entitles any holder hereof to any rights of a stockholder of the Company.

 

    A-2

     

    

 

Election to Purchase

 

(To Be Executed Upon Exercise of Closing Warrant)

 

The undersigned hereby irrevocably elects to exercise
the right, represented by this Closing Warrant Certificate, to receive __________ shares of Common Stock and herewith tenders payment
for such shares of Common Stock to the order of Voltus Technologies, Inc. (the “Company”) in the amount of $
__________ in accordance with the terms hereof. The undersigned requests that a certificate for such shares of Common Stock be registered
in the name of __________, whose address is __________ and that such shares of Common Stock be delivered to __________ whose address is
__________. If said number of shares of Common Stock is less than all of the shares of Common Stock purchasable hereunder, the undersigned
requests that a new Closing Warrant Certificate representing the remaining balance of such shares of Common Stock be registered in the
name of __________, whose address is __________ and that such Closing Warrant Certificate be delivered to __________, whose address is
__________.

 

In the event that the Closing Warrant has been
called for redemption by the Company pursuant to Section 6.2 of the Closing Warrant Agreement and a holder thereof elects to exercise
its Closing Warrant pursuant to a Make-Whole Exercise, the number of shares of Common Stock that this Closing Warrant is exercisable for
shall be determined in accordance with Section 6.2 of the Closing Warrant Agreement.

 

In the event that the Closing Warrant is to be
exercised on a “cashless” basis pursuant to Section 7.4 of the Closing Warrant Agreement, the number of shares of Common
Stock that this Closing Warrant is exercisable for shall be determined in accordance with Section 7.4 of the Closing Warrant Agreement.

 

In the event that the Closing Warrant may be exercised,
to the extent allowed by the Closing Warrant Agreement, through cashless exercise (i) the number of shares of Common Stock that this Closing
Warrant is exercisable for would be determined in accordance with the relevant section of the Closing Warrant Agreement which allows for
such cashless exercise and (ii) the holder hereof shall complete the following: The undersigned hereby irrevocably elects to exercise
the right, represented by this Closing Warrant Certificate, through the cashless exercise provisions of the Closing Warrant Agreement,
to receive shares of Common Stock. If said number of shares of Common Stock is less than all of the shares of Common Stock purchasable
hereunder (after giving effect to the cashless exercise), the undersigned requests that a new Closing Warrant Certificate representing
the remaining balance of such shares of Common Stock be registered in the name of __________, whose address is __________ and that such
Closing Warrant Certificate be delivered to __________, whose address is __________.

 

[Signature Page Follows]

 

    A-3

     

    

 

	Date: __________, 20	 	 
	 	 	(Signature)
	 	 	 
	 	 	(Address)
	 	 	 
	 	 	(Tax Identification Number)
	 	 	 
	Signature Guaranteed:	 	 
	 	 	 

 

THE SIGNATURE(S) MUST BE GUARANTEED BY AN ELIGIBLE GUARANTOR INSTITUTION
(BANKS, STOCKBROKERS, SAVINGS AND LOAN ASSOCIATIONS AND CREDIT UNIONS WITH MEMBERSHIP IN AN APPROVED SIGNATURE GUARANTEE MEDALLION PROGRAM,
PURSUANT TO S.E.C. RULE 17Ad-15 (OR ANY SUCCESSOR RULE) UNDER THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED).

 

    A-4

     

    

 

EXHIBIT B

 

LEGEND

 

“THE SECURITIES REPRESENTED HEREBY HAVE NOT
BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR ANY STATE SECURITIES LAWS, AND MAY NOT BE OFFERED, SOLD, TRANSFERRED
OR OTHERWISE DISPOSED OF UNLESS REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, AND ANY APPLICABLE STATE SECURITIES LAWS OR AN
EXEMPTION FROM REGISTRATION IS AVAILABLE.”

 

 

B-1EX-10.5

 Exhibit 10.5 

CUSTODIAL AGREEMENT 

November 21, 2021 
 Special Opportunities
Capital, LLC 
 c/o EnCap Investments L.P. 
 1100 Louisiana
Street, Suite 4900 
 Houston, TX 77002 
 Attention: Doug
Swanson 
 Re: Securities Custodial Arrangement. 

Ladies and Gentlemen: 
 Reference is made hereby
to the Stock Purchase Agreement, dated November 21, 2021 (the “Stock Purchase Agreement”), by and between Gen IV Investment Opportunities, LLC, a Delaware limited liability company (“Seller”), and Paloma
Partners VI Holdings, LLC, a Delaware limited liability company (“Purchaser”), pursuant to which Seller agreed to sell and Purchaser agreed to purchase, 1,838,510 shares of common stock of, par value $0.01 per share (CUSIP
No. 382410843) (the “Securities”) of Goodrich Petroleum Corporation, a Delaware corporation (“Goodrich”). The parties hereto are affiliates and are entering into this letter agreement (this “Letter
Agreement”) to memorialize their understanding and agreement with respect to a custodial arrangement pertaining to the Securities as set forth below. 

1. Special Opportunities Capital, LLC, a Delaware limited liability company (“Custodian”) agrees, immediately upon and after
settlement of the purchase and sale contemplated in Section 1 of the Stock Purchase Agreement, to hold the Securities as custodian for and on behalf of Purchaser, in Custodian’s prime brokerage account, solely for the benefit of Purchaser,
all upon the terms and conditions and subject to the limitations hereinafter set forth. Purchaser does not have a brokerage account to be used to hold the Securities, and Custodian desires on behalf of its affiliate, Purchaser, to facilitate the
settlement of the transactions contemplated by the Stock Purchase Agreement. 
 2. Purchaser shall beneficially own the Securities. 

3. With respect to the Securities, Custodian shall act solely as custodian and shall solicit and follow the instructions of Purchaser in all
matters relating to the Securities, including following Purchaser’s instructions as to the voting of the Securities in all matters as to which the Securities are entitled to be voted. In the absence of instructions from Purchaser, Custodian
shall not take any action with respect to the Securities. Notwithstanding the foregoing, Custodian shall not be required to take any action that would violate the transfer restrictions and other conditions and limitations to which the Securities are
subject pursuant to the organizational documents of Goodrich, or any applicable law or regulation. For so long as the Securities are held by Custodian, (i) Purchaser shall have sole dispositive and voting power, and sole power to make all other
decisions, in each case, with respect to the Securities and (ii) Purchaser shall be deemed the owner of the Securities for all purposes. 

 4. With respect to the Securities, Custodian is exclusively the bailee of Purchaser, holds
the Securities solely for the benefit of Purchaser, and undertakes to perform such duties and only such duties as are specifically set forth in Letter Agreement. 

5. The Custodian agrees that it will not charge any fees or receive any compensation in discharging its duties under this Letter Agreement.

 6. In the absence of bad faith on the part of Custodian, Custodian may conclusively rely on instructions provided by Purchaser or the
advice of competent attorneys, accountants, and other professionals in taking an action, omitting to take an action, or otherwise discharging its duties under this Letter Agreement. 

7. Purchaser may remove Custodian at any time upon providing written notice of removal. In such event, Purchaser shall appoint a successor
custodian hereunder, or upon written instruction by Purchaser, transfer the Securities to a brokerage account maintained by or on behalf of Purchaser, or take such other action with respect to the Securities as specified by Purchaser. 

8. All notices, requests and other communications to any party hereunder shall be in writing (including electronic mail (“e-mail”) transmission, so long as a receipt of such e-mail is requested and received) and shall be given, 

if to Custodian, to: 
 Special
Opportunities Capital, LLC 
 c/o EnCap Investments L.P. 

1100 Louisiana Street, Suite 4900 

Houston, TX 77002 
 Attention:
Doug Swanson 
 E-mail: dswanson@encapinvestments.com 

with a copy (which shall not constitute notice) to: 

Hunton Andrews Kurth LLP 
 600
Travis Street 
 4200 JPMorgan Chase Tower 

Houston, TX 77002 
 Attention: G.
Michael O’Leary; Henry Havre 
 E-mail: moleary@huntonak.com; hhavre@huntonak.com 

if to Purchaser, to: 
 Paloma
Partners VI, LLC 
 1100 Louisiana Street, Suite 5100 

Houston, TX 77002 
 Attention:
Christopher N. O’Sullivan 
 Email: cosullivan@palomaresources.com 

  
 2 

 with a copy (which shall not constitute notice) to: 

Hunton Andrews Kurth LLP 

600 Travis Street 

4200 JPMorgan Chase Tower 

Houston, TX 77002 

Attention: G. Michael O’Leary; Henry Havre 

E-mail: moleary@huntonak.com; hhavre@huntonak.com 

or to such other address or e-mail address as such party may hereafter specify for the purpose by notice to the other
parties hereto. All such notices, requests and other communications shall be deemed received on the date of receipt by the recipient thereof if received prior to 5:00 p.m. on a business day in the place of receipt. Otherwise, any such notice,
request or communication shall be deemed to have been received on the next succeeding business day in the place of receipt. 
 9. This Letter
Agreement shall be governed by and construed and enforced in accordance with the laws of the State of New York. 
 10. No provision of this
Letter Agreement may be amended, countermanded or otherwise modified without the prior written consent of Purchaser and Custodian. 
 11.
This Letter Agreement may be signed in any number of counterparts, each of which shall be an original, with the same effect as if the signatures thereto and hereto were upon the same instrument, it being understood that the parties need not sign the
same counterpart. Any such counterpart, to the extent delivered by fax or .pdf, .tif, .gif, .jpg or similar attachment to electronic mail (any such delivery, an “Electronic Delivery”), will be treated in all manner and respects as
an original executed counterpart and will be considered to have the same binding legal effect as if it were the original signed version thereof delivered in person. This Letter Agreement shall become effective when each party shall have received a
counterpart hereof signed (including by electronic signature) by all of the other parties hereto. Until and unless each party has received a counterpart hereof signed (including by electronic signature) by the other parties, this Letter Agreement
shall have no effect and no party shall have any right or obligation hereunder (whether by virtue of any other oral or written agreement or other communication). No party may raise the use of an Electronic Delivery to deliver a signature, or the
fact that any signature or agreement or instrument was transmitted or communicated through the use of an Electronic Delivery, as a defense to the formation of a valid and binding contract, and each party forever waives any such defense, except to
the extent such defense relates to lack of authenticity. 
 (Signature Pages Follow) 

  
 3 

 IN WITNESS WHEREOF, this Letter Agreement has been executed by and on behalf of each of the
parties hereto as of the date first written above. 
  

			
	Very truly yours,
	
	PALOMA PARTNERS VI HOLDINGS, LLC
		
	By:	 	 /s/ Christopher N. O’Sullivan

	Name:	 	Christopher N. O’Sullivan
	Title:	 	Chief Executive Officer

  
 [Signature Page to
Custodial Agreement] 

 
			
	ACKNOWLEDGED AND AGREED:
	
	PURCHASER:
	
	SPECIAL OPPORTUNITIES CAPITAL, LLC
		
	By:	 	EnCap Energy Capital Fund XI, L.P.,
		 	its sole member
		
	By:	 	EnCap Equity Fund XI GP, L.P.,
		 	its general partner
		
	By:	 	EnCap Equity Fund XI GP, LLC,
		 	its general partner
		
	By:	 	EnCap Investments L.P.,
		 	its sole member
		
	By:	 	EnCap Investments GP, L.L.C.,
		 	its general partner
		
	By:	 	 /s/ Douglas E. Swanson, Jr.

	Name:	 	Douglas E. Swanson, Jr.
	Title:	 	Authorized Signatory

  
 [Signature Page to
Custodial Agreement]

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00337-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00337-of-00352.parquet"}]]